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1.1 Overview 
In 2005, stroke was the cause for 5.7 million deaths worldwide and was 
identified as the second leading cause of death by the World Health Organization 
(WHO).1  In the United States, stroke is considered as the most life-threatening 
neurological disorder and accounts for one of every fifteen deaths.2  It has also been 
identified as the third leading cause of death and the first leading cause of disability in 
order adults.3  Reports indicate that more than 780,000 new strokes occur each year in 
the United States.4  Many survivors of stroke require extensive care,5  and the health 
consequences of stroke have a substantial economic impact on not only the individual 
and family, but also on the society.6 
Stroke can lead to loss of function both physically and cognitively,7  and the 
severity of stroke dictates the severity of disablement.  Depending on the lesion size 
and location,  the injury to the brain can affect multiple systems.8  These include 
motor and sensory impairments and language, perception, affective, and cognitive 
dysfunction.9  Physical symptoms of stroke usually include weakness or paralysis.  
Most survivors of stroke show some residual loss of function on either the right or left 
side of the body, referred to as hemiplegia or hemiparesis.10   
Secondary conditions in people post-stroke include a higher incidence of 
injury from falls, spasticity, memory loss, aphasia, sleep apnea, back pain, stress, and 
social isolation,9, 11  while some of the common co-morbidities may include coronary 
heart disease, obesity, hypertension, type 2 diabetes, and hyperlipidemia.12  In 
addition, it has been shown that up to 60% of people post-stroke can develop 
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depression;13  and there has been reported a high incidence rate of fatigue in people 
post-stroke as well.11, 14-16  
Only recently, researchers have acknowledged the negative impact of post-
stroke fatigue (PSF);11, 17-19  and the causes of PSF appear multi-factorial.20  However, 
PSF remains under-recognized and under-treated due to limited comprehensive 
investigation, although PSF is potentially a major public health concern.  Therefore, 
the primary purpose of the present work was to differentiate unique types of PSF and 
determine its potential contributing factors.  As a result of this work, we hope to 
obtain a better understanding in the nature of different kinds of fatigue in people with 
chronic stroke, and provide rehabilitation professionals adequate means to construct 
effective therapeutic treatments. 
 
1.2 Stroke 
Stroke is often referred to as a cerebrovascular accident (CVA).  It is defined 
as a sudden, non-convulsive loss of neurologic function due to an ischemic or 
hemorrhagic intracranial vascular event21  with rapidly developing clinical signs of 
focal or global disturbance of cerebral function.  It can be mild with only short-term 
consequences or can cause severe long-term limitations in mobility and cognition. 
Among all segments of the population, African-Americans have a greater risk 
of having a stroke than Caucasians or Hispanics and are more likely to be disabled 
from a stroke.22  The likelihood of having the first stroke varies  with sex and age.9, 23  
Men have a 30 percent greater risk of having a stroke than women in earlier life, 
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while women have a greater risk in later life.9  The risk of stroke increases ap-
proximately 5 percent per year in the 55-59-year-old age group.  In the 80-84-year-
old age group, the increased risk is approximately 25 percent a year thereafter.23   
Stroke is considered a heterogeneous disorder because of its 
pathophysiology.8  It can involve the rupturing of a large blood vessel in the brain,8  
also known as hemorrhagic stroke, which constitute approximately 10 percent of all 
strokes.9  A hemorrhagic stroke results in blood leaking into the extravascular space 
within the cranium or into the brain tissue itself.  Depending on where the injury 
occurs, hemorrhagic strokes can be classified as intra-cerebral (bleeding directly into 
the brain) or subarachnoid (bleeding into the spaces and spinal fluid around the 
brain).  This bleeding damages the brain by cutting off connecting pathways and by 
causing localized or generalized pressure injury to brain tissue.8 
Stroke can also involve the occlusion of a small blood vessel that affects a 
certain area of the brain,8  also known as ischemic stroke, which makes up 
approximately 90 percent of all strokes.9  It originates from a restricted blood supply, 
resulting in cell damage and impaired neurological function.9  Ischemic strokes are 
divided into two types: thrombotic and embolic.  Thrombosis refers to an obstruction 
of blood flow due to a localized occlusion within one or more blood vessels.8  
Thrombotic infarction occurs when a thrombus forms on an atherosclerotic plaque, 
while embolic infarction results when a material (embolus) is formed elsewhere and 
travels through the vascular system occludes an artery or arteriole in the brain.24 
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1.3 Fatigue 
1.31 Historic View 
Fatigue is one of the most common health complaints25, 26  and is an important 
component of many physical diseases and psychiatric disorders.27  It affects 
approximately 10-45% of community dwellers and patients who require primary 
care.25, 28  Fatigue is a subjective feeling and is difficult to define.  It can be 
represented either as a single phenomenon or a continuous event.29 
Fatigue remains as difficult to measure as it was decades ago.  Due to its 
ambiguous and subjective nature, researchers had proposed to banish the terminology 
and its related investigations from scientific discussion in the early 1920’s.30  Others 
decided to revisit this matter in the early 1940’s.31  After the late 1980’s, more 
attempts have been made to investigate fatigue objectively and subjectively and 
theories started to emerge.25, 29, 32-35  
 
1.32 Fatigue Redefined.   
Literature suggests that fatigue is a complex and multidimensional 
phenomenon that can be defined from different perspectives.32, 35-37  Since the 
perception of fatigue is subjective,29  synonyms used to describe fatigue may be 
interpreted differently among individuals.  For example, “feeling tired all the time” is 
more commonly used than “feeling weak.”38  This ambiguity makes the study of 
fatigue challenging.  In the literature, many definitions of fatigue have emerged from 
different perspectives and disciplines. 
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In less restrictive terms, it is generally agreed to define fatigue as a subjective 
sensation of tiredness or lack of energy, and is experienced by most people at one 
time or another.39  It has also been described as the inability to maintain the force or 
the production of force40  and the inability to maintain sustained thought or mental 
ability.41  In 1999, Aaronson and colleagues defined fatigue as the awareness of a 
decreased capacity for physical and/or mental activity due to an imbalance in the 
availability, utilization, and/or restoration of resource needed to perform activity.37  In 
2001, Staub and colleagues proposed that fatigue is defined as the feeling of early 
exhaustion, weariness, lack of energy and aversion to effort.17  In 2004, the North 
American Nursing Diagnosis Association (NANDA) defined fatigue as an 
overwhelming, sustained sense of exhaustion and decreased capacity for physical and 
mental work.42 
All these definitions suggest that fatigue is determined by a person’s 
subjective feeling about the state of one’s internal resource and the nature of the 
activity being performed.  However, the definition of global fatigue does not satisfy 
the view from other perspectives.  For example, from the physiologic perspective, 
fatigue can be defined as reaching the maximal capacity of cardiopulmonary 
function43  or maximal oxygen uptake (VO2max), the product of maximal cardiac 
output and maximal arteriovenous oxygen difference as part of the oxidative 
metabolism process.  On the other hand, fatigue can also be defined as a loss of 
maximal force-generating capacity during muscular activity, likely originates within 
muscle itself, and persists until muscle is fully recovered.43  Piper and colleagues 
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described fatigue as a multicausal, multidimensional sensation that affects sensory, 
affective, behavioral, and physiologic realms.32  Using Piper’s multidimensional view 
of fatigue as a conceptual framework, fatigue was defined as a sensation of depletion 
of internal resource, regardless of what nature or type of such resource may be in this 
dissertation project. 
 
1.33 Fatigue Models. 
The causes of fatigue remains debated.  Nevertheless, several fatigue models 
have emerged since the 1980s.  In 1989, Funk and colleagues proposed a 
neurophysiological model in an attempt to explain fatigue in terms of central and 
peripheral nervous system components.33  They suggested that impairment of the 
central component leads to decreased motivation and transmission of messages from 
the brain and spinal cord.  It also leads to exhaustion of brain cells in the 
hypothalamic region.  Impairment of the peripheral component can change complex 
biochemical interactions between nerve and muscle that generate the force to 
movement.33  Some researchers have described fatigue models from a physiological 
perspective. 
In 1992, St. Pierre and colleagues demonstrated that physical symptoms of 
fatigue can be induced via alterations in metabolite concentration level.44  Others 
have suggested a causal role of decreased aerobic capacity,45  decreased muscle 
strength, endurance,46  and increased oxygen consumption needs47  to describe 
fatigue. 
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In addition, Bruno and colleagues proposed a viral damage model in 1993 to 
describe fatigue in patients with post-polio.48  It was suggested that the effects of viral 
damage to the neurons of the reticular activating system impair the ability to maintain 
attention and leads to “brain fatigue,” a symptom commonly experienced among 
survivors of polio described as a sensation of diminished concentration and 
drowsiness. 
In 1987, Piper, Lindsay, and Dodd addressed the multidimensional nature of 
fatigue and suggested that the contributing factors of fatigue can be perceptual, 
physiological, biomechanical, and behavioral.32  More specifically, Piper and 
colleague recognized the distinction between the objective dimensions (physiological, 
biomechanical, and behavioral) and the subjective dimension of fatigue (perception).  
In1989, Piper and colleagues further defined the subjective dimension of fatigue with 
7 subdimensions (temporal, intensity, affective, sensory, evaluative, associated 
symptoms, and relief).49  Figure 1.1 illustrates the conceptual framework of Piper’s 
fatigue model developed based on cancer patients.  It was believed that subjective 
dimension gives insight into how patients experience and better serves the research 
interest within the nursing science discipline.50  Although the subjective 
subdimensions were abstract and less specific, Piper’s view of fatigue suggests that 
fatigue cannot always be measured or explained objectively.   
Based on the biochemical dimension described in Piper’s fatigue model, 
Payne and colleagues investigated fatigue, sleep disturbances, and depressive 
symptoms in women with breast cancer by evaluating the changes in serum 
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biomarkers levels during chemotherapy.51  Payne’s study included 11 women with 
stage II breast cancer receiving adjuvant chemotherapy and 11 people with no cancer 
as age-matched controls.  Fatigue, sleep, and depressive symptoms were assessed by 
questionnaires, and serum samples were analyzed for biomarkers including serum 
cortisol, melatonin, serotonin, and bilirubin.  The authors concluded that fatigue, 
sleep, and depressive symptoms are more prevalent in women with cancer than a 
cancer-free comparison group.  In addition, it was suggested that serotonin, cortisol, 
and bilirubin can provide a possible explanatory mechanism for fatigue-related 
symptoms.  This finding confirmed the theoretical framework based on the 
biochemical dimension of Piper’s fatigue model; however, it does not address the 
multidimensional nature of fatigue as Payne’s study only emphasized a singular 
dimension. 
Piper’s fatigue model also provided other researchers a theoretical framework 
to investigate the nature of fatigue.  In 1999, Portenoy and colleagues conducted a 
review study and proposed an integrated fatigue model which consists of physiologic 
and psychosocial dimensions and several potential contributing factors.52  Although 
based on cancer patients, Portenoy’s integrated fatigue model was applicable to other 
clinical population such as people post-stroke due to several overlapping factors as 
illustrated in Figure 1.2.  Consistent with Piper’s view, this integrated fatigue model 
considers the multifactorial and multidimensional nature of fatigue, as recent studies 
have also suggested.36, 37 
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1.34 Fatigue Classifications. 
Commonly, fatigue refers to a normal, everyday experience that most 
individuals report after exertion of physical power, inadequate sleep, or use of mental 
effort.35  However, this definition does not distinguish the nature of different types of 
fatigue.  Piper described a dichotomy fatigue concept,53  which classifies fatigue as 
either acute or chronic, with duration of fatigue symptoms as the key discriminating 
factor as illustrated in Figure 1.3.  This dichotomy fatigue concept is a broader 
interpretation of the original fatigue model32  developed based on patients with 
cancer.  It was proposed that other differentiating factors between acute and chronic 
are the onset of fatigue and the patient’s recovery rate. To be specific, it was 
described that acute fatigue (Appendix I) has fast onset and quicker recovery. 
It has been recently suggested that fatigue is not necessarily a symptom of 
disease but may be a daily experience of persons in the general population.54  
Consistent with Piper’s dichotomy fatigue concept, researchers have distinguished 
this type of fatigue as “exertion fatigue (EF)” that is normative and is caused by 
extensive activities throughout daily living (Appendix I).53, 55, 56  It is a state of 
general tiredness that is the result of over-exertion and can be recovered by rest.  This 
type of fatigue is acute in nature, with a rapid onset and shorter duration. 
On the other hand, “chronic fatigue (CF)” is differentiated from the normative 
types of fatigue and is associated with prolonged stress or pathologies(Appendix I).53, 
56  It is a state of weariness unrelated to previous exertion levels and is usually not 
alleviated by rest.  This type of fatigue is chronic in nature with multiple possible 
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causes, and is perceived to be abnormal or excessive.  Unlike EF, CF may indicate a 
symptomatic condition of disease.  In fact, CF is the symptom most frequently 
reported in the presence of many physical diseases, especially chronic ones such as 
cancer and multiple sclerosis.25, 32, 33, 57  CF is also the key symptom of chronic fatigue 
syndrome (CFS), a condition which has gained much attention since the early 
1990’s.25  The cause of CF is uncertain; but several factors may contribute to chronic 
fatigue such as depression, sleep disorders, medical treatment, and medications.  
More specifically, medical treatment for cancer such as radiotherapy or chemotherapy 
has been shown to induce chronic fatigue in patients.32, 35, 57  Long-term usage of 
medications such as sleep agents also induces chronic fatigue.35  In addition, it has 
been suggested that depression may be a key contributing factor to CF.14, 58-60 
 
1.4 Fatigue Scales 
1.41 Previous Fatigue Scales 
Many attempts have been made in order to transform fatigue into a 
quantifiable measure.27, 29, 34, 35, 50, 54, 55, 57, 61  To date, it is controversial to determine 
which fatigue scales are the most accurate and appropriate to assess PSF.  
Nevertheless, it has been suggested that the appropriateness of a fatigue scale should 
be determined by aspects of fatigue that are being measured.62 
In 1989, Piper and colleagues developed the original Piper Fatigue Scale 
(PFS) to measure fatigue in cancer patients.50  It consisted of 41 items along with 
visual analogue scale.  However its length prevented it from becoming a practical 
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research or clinical tool.  In 1998, Piper and colleagues made an attempt to reduce the 
total number of items in PFS and to confirm the multidimensionality of the 
questionnaire.57  It was a part of a larger mailed survey study conducted in urban and 
suburban areas in the northeast United States.  More than 2,000 surveys were 
distributed to breast cancer survivors and 715 surveys (32%) were returned.  Of all 
the respondents, 382 women met the study's criteria.  The revised version consists of 
22 questions divided into four subscales that measure behavioral/severity (6 items), 
affective meaning (5 items), sensory (5 items) and cognitive/mood (6 items).  Despite 
the multidimensional approach of the revised PFS, the results revealed redundancy of 
the scale and further revision was suggested. 
Chalder et al. in 1993 developed the Chalder Fatigue Scale (CFS) to measure 
the severity of fatigue.29  It consists of 14 questions which measure mental and 
physical symptoms of fatigue.  Three hundred and forty-seven subjects between the 
ages of 18 and 45 were asked to complete the test in a clinical setting in England.  
The results revealed a high degree of internal consistency for all items (Cronback’s 
alpha 0.88 - 0.90).  In addition, the original 14 items were placed into two different 
factors to describe physical (items 1-8) and mental (item 9-14) fatigue.  In 1998, 
Morriss and colleagues revisited the validity of the CFS in 136 patients with chronic 
fatigue syndrome.63  The original 14 items were categorized into 4 factors – cognitive 
difficulties, tiredness and sleepiness, strength and endurance, and loss of interest and 
motivation, which accounted for 67.1% of total variance in the scores on the fatigue 
scale.  Their results agreed with Chalder et al and demonstrated validity of the scale.  
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However, some items in the CFS were significantly associated with more than one 
factor and can be interpreted differently.  For example, the item “problems starting 
things” was associated with both Factor 1 - cognitive difficulties (factor loading index 
= 0.49) and Factor 4 - loss of interest and motivation (0.46); and the item “lacking 
energy” was associated with both Factor 2 - tiredness and sleepiness (0.69) and Factor 
3 - strength and endurance (0.42).  Such items make distinction between EF and CF 
difficult; therefore CFS was not considered in this project. 
Other researchers also attempted to measure the multidimensional aspect of 
fatigue.  In 1995, Smets and colleagues developed a five-dimensional fatigue scale 
that did not intend to contain any confounding somatic items.35  The 
Multidimensional Fatigue Inventory (MFI-20) consists of 20 items divided into five 
subscales with a visual 5-point Likert scale.  The five subscales include general, 
physical, mental fatigue, reduction in activity, and reduction in motivation; and each 
subscale yields four items.  The questionnaire was tested for its psychometric 
properties in cancer patients receiving radiotherapy (n=111), patients with the chronic 
fatigue syndrome (n=357), psychology students (n=481), medical students (n=158), 
army recruits (n=160 & 156) and junior physicians (n=46).  The results showed 
validity of the MFI-20 with an internal consistency (Cronbach's alpha = .84).  
Construct validity was established after comparisons between and within groups, and 
convergent validity was investigated by correlating the MFI-scales with a Visual 
Analogue Scale measuring fatigue (0.22 < r < 0.78).  However, a later study by 
Schneider only partially supports the MFI-20.61  In Schneider’s study, the same MFI-
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20 scale was administered to 97 cancer patients to replicate internal consistency and 
reliabilities of the MFI-20.  The results showed that three of the five subscales from 
the MFI-20 reported moderate to low internal consistency (Cronbach's alpha = 0.43 - 
0.64); and the author suggested using the General Fatigue subscale as a global 
indicator to represent fatigue.  Despite the high internal consistency (Cronbach's 
alpha of 0.74) found in the General Fatigue subscale, it only yields 4 items and may 
not be well-constructed enough to detect fatigue.  In addition, some items in the MFI-
20 are related to either behavioral or psychosocial consequences which may be 
confounding. 
Michielsen et al. in 2003 proposed a 10-item Fatigue Assessment Scale (FAS) 
that measures psychometric qualities of fatigue in 351 people with a minimum of 20 
working hours per week.27  Out of the 10 items composing the FAS, 1 item was novel 
and 9 were selected from an item pool consisting 40 items taken from other 
commonly used fatigue questionnaires.  The results showed an internal consistency of 
0.90.  However, this questionnaire is fundamentally unidimensional and was 
conducted in a non-pathological population.  The test-retest reliability and the validity 
may be questionable in specific clinical population such as people post-stroke. 
 
1.42 Measuring Chronic Fatigue 
Among all existing fatigue scales, one particular scale appears to adequately 
identify and measure CF.  In 1989, Krupp and colleagues developed a nine-item 
Fatigue Severity Scale (FSS) for subjects with multiple sclerosis and with systemic 
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lupus erythematosus to compare fatigue in two chronic conditions.34  The FSS 
measured level of fatigue in the previous 2-weeks and was administered with a 7-
point Likert scale to 25 subjects with multiple sclerosis, 29 subjects with systemic 
lupus erythematosus, and 20 healthy adults.  The results revealed that the FSS was 
internally consistent.  It also showed that fatigue had a greater impact on daily living 
in patients with multiple sclerosis and systemic lupus erythematosus than controls; 
while fatigue can exist independently of depressive symptoms.  Krupp and colleagues 
demonstrated a clinically feasible method to identify the features that distinguish CF 
using the FSS. 
In 2006, a study by Schepers and colleagues64  examined the relation between 
fatigue at 1 year post-stroke and personal characteristics, stroke characteristics, and 
post-stroke impairments.  One hundred and sixty-seven people post-stroke were 
included in this study via inpatient rehabilitation programs from 4 Dutch 
rehabilitation centers.  The FSS was administered to measure fatigue at 3 different 
time points – initial admittance for inpatient rehabilitation, 6 months, and 1 year post-
stroke.  The results demonstrated intraclass correlation coefficient (ICC) of 0.82 and 
internal consistency (Cronbach's alpha of 0.89) in people post-stroke. 
The FSS emphasizes the impact of fatigue on daily life in terms of 
accumulation of functional fatigue effects, which appears suitable for detecting the 
presence and the severity of CF.  Furthermore, the FSS has been recently used to 
measure fatigue in several PSF studies.11, 16, 64-66  In this dissertation project, the FSS 
was used as one of the measures to assess CF in people post-stroke. 
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1.43 Measuring Exertion Fatigue 
Since EF is a relatively overshadowed concept due to the prevalence of CF in 
many clinical populations, very few investigators have attempted to develop a 
quantifiable scale to measure EF.  In 1998, Tiesinga and colleagues proposed that the 
Dutch Exertion Fatigue Scale (DEFS) can be used to assess EF in patients with heart 
disease, postpartum women, and patients living in a home for the elderly.55  Although 
they attempted to differentiate EF from generic fatigue, the DEFS has not been 
validated in people with chronic stroke.  
In 2005, Yang et al proposed the Situational Fatigue Scale (SFS) that specifies 
the nature and the duration of daily activities in which subjects estimate their level of 
fatigue subjectively.54  They suggested that most fatigue scales allow subjects to rate 
their level of fatigue without specifying the situation.  Yang and colleagues further 
argued that the level of fatigue is determined not only by the availability of inner 
resources but also by the demands of the activities performed, therefore duration and 
type of activity must be specified when measuring fatigue.  The SFS was 
administered as a survey to 96 outpatients in a family-medicine clinic and to 63 
college students.  The results revealed internal consistency and test-retest reliability 
and suggested that the SFS could be a useful tool to measure the broad concept of 
fatigue.  However, many items in the SFS were too specific to the types of activity 
involved and may not be applicable to clinical population with physical limitations. 
In 2006, Smith and colleagues conducted a pilot study to look at changes 
before and after a single bout of exercise in 34 people with multiple sclerosis.67  They 
 17
collected data in function, fatigue, and sensory symptoms before exercise, 
immediately after exercise, and 24 hours later.  Subjects were asked to exercise 
between 5 to 45 minutes (mean = 17.4 min) at an individually prescribed intensity of 
7 to 17 (median = 12) on the Borg’s Rating of Perceived Exertion (RPE) scale.68, 69  It 
is important to acknowledge that the RPE reflects the perceived level of exertion 
during exercise, not the level of fatigue after exercise.  In addition, Smith and 
colleagues used a self-reported visual analog scale with score ranges from 1 to 100 to 
measure the intensity of fatigue.67  All outcome measures were self-rated by subjects.  
Although no significance was found in fatigue levels between pre-exercise, 
immediately post-exercise and 24 hours post-exercise, Smith and colleagues provided 
methodological groundwork to measure EF in clinical populations.  Furthermore, the 
visual analog scale has been used in recent studies to investigate fatigue in people 
post-stroke.16, 65, 70  In this body of work, a similar visual analog scale was developed 
specifically for people post-stroke and was used to detect fatigue with different 
natures. 
Despite all previous efforts to investigate fatigue with various approaches, not 
many scales were designed to differentiate EF from CF; and all existing fatigue scales 
lack objective measurement to validate the presence of fatigue with physiologic 
responses and changes.  This dissertation project attempted to address these issues by 
1) developing a clinically feasible scale that could detect either EF or CF each with its 
unique assessment method, and 2) validating the scale with physiologic response and 
changes during exercise testing. 
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1.5 Post-Stroke Fatigue 
Post-stroke fatigue (PSF) is a prevalent symptom among survivors of stroke,11, 
14-17, 20, 71, 72  with an incidence rate as high as nearly 70%.11, 64  However, it is a 
commonly neglected issue by clinicians as well as care-givers.11, 14-17 
In an earlier PSF study, Ingles and colleagues11  conducted a survey study in a 
community setting in order to investigate the frequency and outcome of fatigue, its 
impact on functioning, and its relationship with depression in people post-stroke.  
They administered a self-report questionnaire known as the Fatigue Impact Scale 
(FIS)73  to 181 people post-stroke.  The FIS measures the presence and severity of 
fatigue and its impact on cognitive, physical, and psychosocial functions.  In addition, 
a Geriatric Depression Scale (GSD)74  was also administered to detect depressive 
symptoms.  To meet the inclusion criteria, the participants must have a cerebral 
infarct or an intracerebral hemorrhage and was discharged from the hospital.  They 
were excluded from the study if (1) they had experienced another stroke after 
admission of study; (2) abused alcohol or had another neurologic disease; (3) did not 
speak English; or (4) they were unable to answer questions or complete self-rating 
questionnaires due to cognitive impairment.  Eighty-eight participants (33 women, 55 
men) ranged from 27 to 91 years of age (mean = 66.6, SD = 13.4) between 3 and 13 
months post-stroke (mean = 212 days, SD = 85.3) met the criteria.  The control group 
consisted of 56 elderly participants (38 women, 18 men) ranged from 62 to 93 years 
of age (mean = 73.9, SD = 7.9).  They were excluded if they had a history of stroke, 
neurologic disease, or alcohol abuse.  The results found that 68% of 88 people 
 19
reported fatigue problems, greater than the control group (36%, p < .001); 40% 
percent of the stroke group reported that fatigue was among their worst symptom.  
Surprisingly, fatigue was not found related to time post-stroke, stroke severity, or 
lesion location.  Although the presence of fatigue was independent of depression, the 
authors concluded that fatigue can contribute to functional impairment even long after 
the onset of stroke (i.e. 13 months) and suggested that the treatment to post-stroke 
fatigue is important for stroke recovery. 
In 2001, Van der Werf and colleagues conducted a survey study by mail in 
people with at least 1 year of time post-stroke.14  The purpose of this study was to test 
whether fatigue persists long after a stroke has occurred, and to assess the relation 
between fatigue and levels of physical impairment and depression.  One hundred and 
thirty-eight participants were mailed the questionnaire and were asked to find an age-
match control without previous history of stroke to fill out an additional 
questionnaire.  Sixty-five percent of the stroke group and 37% of the control group 
responded.  In this study, fatigue was measured using the Checklist Individual 
Strength (CIS),75  a 20-item self-report questionnaire that quantifies subjective fatigue 
and related behavioral aspects; while the functional disability was measured by 
Sickness Impact Scale (SIP) consists of 7 subscales.76  The results showed that 50% 
of people post-stroke experienced fatigue as their main complaint, significantly more 
frequent than the 16% in the control group.  There was a significant difference in 
functional impairment between groups and no significant difference was found in 
depression.  Consistent with Ingle and colleague’s findings in 1999, Van der Werf et 
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al. suggested that fatigue can persist long after stroke.  They also found that physical 
impairment and depression were related to levels of fatigue but were not related to 
time post-stroke.  In addition, walking impairment explained most of the variance in 
the stroke group. 
In 2002, Glader et al. collected responses from people approximately 30 
months post-stroke to investigate post-stroke fatigue in Sweden.15  The purpose of 
this large study was to determine the prevalence of fatigue independent of depression 
in people post-stroke and the impact fatigue on different aspects of daily life.  Of the 
8194 patients registered in a hospital-based national stroke register, 5189 lived past 2 
years after stroke and 4023 (77.5%) responded a mail questionnaire.  In this study, 
individuals who reported persistent depressive symptoms were excluded.  The results 
revealed that of the 3667 stroke survivors who returned the questionnaire and met the 
criteria, 39.2% reported moderate to severe fatigue in spite of the absence of 
depressive symptoms.  Three years after stroke, patients with fatigue also had a 
higher fatality rate than those without (17.3% versus 7.1%, p < .001).  Glader and 
colleagues concluded that fatigue is frequent and can be severe even late after stroke, 
which is consistent with previous findings.11, 14  The authors also pointed out that PSF 
usually receives little attention by healthcare professionals and intervention studies 
were suggested. 
In 2005, a study of Korea evaluated the characteristics of and the factors 
associated with PSF.16  Via mail-surveys, Choi-Kwan and colleagues studied 220 
outpatients at an average of 15 months after the onset of stroke.  The presence of PSF 
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was assessed using the Fatigue Severity Scale (FSS)34  and the impact of post-stroke 
fatigue on patients' daily activities was also measured using Fatigue Impact Scale 
(FIS).73    In addition, presence of post-stroke depression and post-stroke emotional 
incontinence were also identified with questionnaire.  The results reported that 57% 
of 220 people 15 months post-stroke had fatigue problems and 24% had post-stroke 
depression.  In addition, 50% of the people without post-stroke depression also post-
stroke fatigue.  Like previously suggested,11, 14, 15  Choi-Kwan and colleagues also 
concluded that fatigue is a common complaint among people post-stroke, and it can 
be independent of depression. 
 
1.6 Contributing Factors to PSF 
1.61 Overview of Potential Factors 
In 2003, de Groot and colleagues conducted a comprehensive literature review 
to address PSF.20  They examined the phenomenon of fatigue in stroke and other 
neurologic disorders and suggested treatment strategies by reviewing the occurrence, 
frequency, duration, severity, and associated factors of fatigue.  de Groot and 
colleagues evaluated the purpose, design, and conclusions from over 1000 articles to 
determine the validity and relevance to the topic of PSF.  Their findings highlighted 
numerous potential contributing factors specific to PSF.  Similar to Portenoy’s 
integrated fatigue model,52  this model consists of physiologic and psychologic 
factors as two distinct dimensions as illustrated in Figure 1.4.  Physiologic factors 
include immobility or inactivity, biochemical abnormalities, systemic disorders, 
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medication side effects, sleep disorders, and altered nutritional status; psychological 
factors include comorbid mood disorders, increase of perceived effort, and illness 
related stressors.  Specifically, physiologic factors that are commonly experienced in 
people post-stroke such as physical deconditioning and physical impairment are listed 
as potential contributors to PSF; while another prevalent post-stroke comorbidity – 
depression, is included as a potential psychological contributing factor.  These 
findings help to identify the parameter of potential contributing factors specific to 
PSF.  In this body of work, we examined three variables that are considered 
substantial contributors to PSF - aerobic fitness,10, 77, 78  physical impairment,14, 15, 65  
and depression.11, 14-16 
 
1.62 Aerobic Fitness 
People post-stroke have diminished aerobic fitness.10, 45, 77, 79  Previous studies 
have assessed the peak oxygen uptake (VO2peak) of stroke survivors77, 79 and reported 
low peak VO2 levels (13 ml/kg/min ~ 16 ml/kg/min) among people post-stroke, 
which is only 50% of healthy older adults.  A comparable reduction was reported in 
maximal walking velocity (1.02+/-0.28m/s) and endurance (294.1+/-120.2m) by 
conducting a six-minute-walk test.78, 80  This reduced VO2peak may be attributed to a 
reduction in the number of motor units capable of being recruited during dynamic 
exercise, the reduced oxidative capacity of paretic muscle,81 and the sedentary 
lifestyle of most stroke survivors.79 
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In 2006, Michael and colleagues investigated how aerobic fitness, mobility 
deficit, ambulatory activity, self-efficacy for falls, and social support are related to 
fatigue in 53 people post-stroke.65  The severity of fatigue was examined using 
Fatigue Severity Scale (FSS)34  and the Visual Analog Scale (VAS);82  aerobic fitness 
was assessed at the peak level using a graded exercise protocol on a treadmill.  In 
addition, timed 10-meter walks, the Berg Balance Scale, total daily step activity, the 
Medical Outcomes Study Social Support Survey, and the Falls Efficacy Scale were 
also administered.  They found that 46% of people post-stroke had severe fatigue; 
fatigue showed an inverse relationship with falls efficacy and social support, but not 
with aerobic fitness or ambulatory activity.  Although their finding did not show a 
direct association between aerobic fitness level and PSF, aerobic exercise has been 
shown to increase aerobic fitness after stroke,77, 78  and its effects on PSF is a subject 
worthy of study.  In this study, VO2peak was assessed as a potential predictor of PSF 
using a maximal effort graded exercise test on a total body recumbent stepper.83 
 
1.63 Physical Impairment 
Physical impairment is considered a contributing factor to PSF due to some 
limitations in people post-stroke, such as decreased strength, limited range of motion, 
muscle tone, mal-alignment, abnormal synergy, and poor coordination, which lead to 
poor biomechanical efficiency.  Specifically, people post-stroke often experience the 
increased energy expenditure of hemiparetic gait due to the inability to activate 
normal motor patterns.84 
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To investigate the physical impairment issues, Pohl and colleagues evaluated 
the walking performance in people post-stroke.85  Seventy-two people with chronic 
stroke were asked to complete the 6-minute walk test (6MWT); pulse and blood 
pressure were taken before and after the walk. Motor control ability was measured by 
the Fugl-Meyer lower extremity (FMLE) motor score; balance was measured by the 
Berg Balance scale (BBS).  Using regression analysis, the authors found that the 
FMLE and BBS explained 45 percent of the variance in distance walked and 
concluded that stroke-related neuromuscular impairments contribute to diminished 
performance in the 6-minute walk test.  As confirmed in later research,86  people post-
stroke show changes in the motor control strategies as demonstrated in abnormal 
muscle activation patterns. 
More interestingly, researchers have found that in people post-stroke, even 
extremities of the less-affected side demonstrate weakness and incoordiantion,87-89  
which may be a contributing factor for fatigue.  In 2003, Kim and colleagues 
examined targeted movements in both the ipsilateral and the contralateral extremities 
in people post-stroke.89  Ten right-handed individuals who were more than 6 months 
post-stroke with Fugl-Meyer motor assessment scores greater than 75% participated 
in this study.  In addition, 20 age-matched adults without stroke comprised the control 
group for comparison.  The outcome measures included movement time and dwell 
time of hand or foot.  The results revealed that regardless of target size, movement 
and dwell times for both upper extremities of the stroke group were prolonged 
compared with those without stroke; while dwell time for both lower extremities of 
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the stroke group was also longer than the control group. The authors then concluded 
that although subtle, the ipsilateral extremities may show motor control deficits after 
stroke.  This finding invites the investigation to determine whether or not physical 
impairment contributes to fatigue in people post-stroke. 
Some researchers have measured muscular strength in order to describe 
PSF.90, 91  In 2007, Hidler et al conducted an electromyography (EMG) study to 
examine the diminished strength and abnormal synergy patterns in people post-
stroke.91  Ten people post-stroke and nine age-match controls participated in the study.  
EMG was used to recorded muscle activations during maximum isometric 
contractions in a standing position.  In addition, joint torques at the knee and hip were 
measured.  Their results indicate that stroke subjects demonstrated significantly lower 
maximum isometric torque than age-matched control subjects.  The EMG data also 
indicate that the stroke group subjects activated antagonistic muscle groups 
significantly higher than the control group.  The authors concluded that poor 
volitional torque generating capacity is a primary contributor to lower limb motor 
impairment in acute hemiparetic stroke. 
Although dynamometer and EMG provide direct measurement of force output 
and muscle activation, respectively, muscular strength does not reflect the motor 
control issue commonly experienced in people post-stroke in order to describe PSF.92  
In 1999, Svantesson and colleagues examined muscular fatigue in people post-stroke 
in order to investigate mechanisms behind fatigue affected by stroke.  Subjects were 
asked to perform repetitive eccentric-concentric plantar flexions on a dynamometer 
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until exhaustion.  The mean power frequency and root mean square of the EMG were 
recorded.  However, the results did not report any significant differences in number of 
repetition performed or work between any of the tested legs in the stroke group.  The 
authors concluded that in people post-stroke there may be other peripheral fatigue 
factors not reflected in the EMG activity. 
In this dissertation project, motor control was assessed as a potential predictor 
of PSF.  The assessment was conducted using the Fugl-Meyer (FM) test.93  The FM 
was specifically designed as a clinical measure of sensorimotor impairment for 
stroke;93  it has been shown to be a reliable and valid tool to assess level of motor 
control in people post-stroke.80, 85, 94  Furthermore, several researchers have used FM 
as an indicator of stroke severity or impairment.95-97  In this study the level of motor 
control was reflected by the FM total motor score (FMTM), which consisted of the 
combined scores from the upper extremity (UE) and the lower extremity (LE) 
portions of the FM test.   
  
1.64 Depression 
Depression is commonly associated with fatigue; and the close relationship 
between depression and fatigue has been recognized in people with multiple 
sclerosis,98-100  epilepsy,101  systemic lupus erythematosus,102  and HIV.103  In 
addition, depression is also associated with other psychiatric disorders such as 
increased risk for suicide and treatment resistance,104  with adds to the severity of its 
comorbidities. 
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Like people post-stroke, patient with multiple sclerosis (MS) also experiences 
fatigue.34  Depression is a prevalent issue in people with MS; and it affects as many 
as 60% of patients.99, 105  In a study that investigated the impact of fatigue and 
depression on quality of life (QOL) in people with MS,58  Janardhan et al examined 
studied 60 patients with MS.  QOL was assessed using Multiple Sclerosis Quality of 
Life (MSQOL)-54; fatigue was assessed using the Fatigue Severity Scale (FSS); and 
depression was measured using the Hamilton Depression Inventory.  The results 
indicate that fatigue and depression are significantly associated with lower QOL 
scores; and both fatigue and depression are independent predictors of impaired QOL 
in patients with MS.  The authors concluded that recognition of fatigue and 
depression is important for effective treatment to improve QOL in patients with MS. 
In people post-stroke, depression is the only identified factor with a significant 
relation to PSF.14, 59, 106  Nevertheless, fatigue is frequent and can persist late after 
stroke;15  more interestingly, it can exist independently of depression11, 14-16  In 1999, 
Ingles and colleagues conducted a survey study to study PSF and its relationship with 
depression in people post-stroke.11  They administered the self-reported Fatigue 
Impact Scale (FIS) that measures the presence and severity of fatigue and its impact 
on cognitive, physical, and psychosocial functions to 181 people post-stroke.  In 
addition, they also administered the Geriatric Depression Scale (GDS) to measure the 
severity of depressive symptoms as did in our study.  Out of the 88 participants who 
met the criteria and participated, they found that 68% of participants reported fatigue 
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problems, while 40% of which were depressed.  This finding revealed the prevalence 
of depression in people post-stroke.  
In addition, a Korean study in 2005 evaluated the characteristics of and the 
factors associated with PSF in 220 people post-stroke.16  Choi-Kwan and colleagues 
reported that 57% of 220 people 15 months post-stroke had fatigue problems and 
24% had depression.  In addition, 50% of the people without depression also had PSF 
complaint.  Consistent with Ingle’s finding, they found the prevalence of fatigue 
among people post-stroke.  In addition, it was also suggested that fatigue can exist 
independently of depression. 
Previously researched has suggested that depression should be considered 
when investigating PSF66  while acknowledging other factors may also play a role as 
a contributor.64  In this dissertation study, depression was examined as an important 
determinant of PSF using the Geriatric Depression Scale (GDS).74 
 
1.65 Lesion Characteristics 
In people post-stroke, the relationship between the presence of fatigue and 
stroke subtype and lesion location has been controversial.  Recent neurobehavioral 
studies suggested that fatigue may be linked to the interruption of neural networks.17  
In contrast, some researchers proposed that stroke subtype or lesion side did not seem 
to be related to PSF.11, 15, 16 
In 1995, Sisson examined the relationship between emotional, behavioral and 
cognitive status and functional activity status in people post-stroke.107  Fifteen right 
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hemisphere stroke survivors were included in this study.  Their finding suggests a 
relationship between right-hemispheric strokes and fatigue or lack of energy.107  It has 
been hypothesized that the subjective feeling of lack of energy is a result of 
disconnection between the right insula and the frontal lobe.108 
In a in 2001 study, Staub and colleagues17  found that fatigue was found 
mainly in people with a brainstem infarct at 54.5%, less often in people with 
subcortical infarct at 37.5%, and rarely in people with cortical infarct at 6.25%.  
However, no significant correlation was found between fatigue and stroke severity, 
lesion location, cognitive and neurological impairment and depression.  Despite the 
results, the authors proposed that PSF may be linked to attentional deficits resulting 
from specific damage to the reticular formation and related structures involved in the 
subcortical attentional network.  It was also suggested that fatigue may develop after 
stroke in connection with cognitive sequelae, neurological impairment, psychological 
factors and sleep disorders. 
On the contrary, some researchers have suggested that stroke subtype and 
lesion side or location did not seem to be related to post-stroke fatigue.11, 14-16, 64  In a 
survey study by Ingles et al., the frequency and outcome of fatigue, its impact on 
functioning, and its relationship with depression in people post-stroke was 
investigated.11  The results of this study demonstrated that fatigue is not related to 
lesion side and location.  Glader et al. also found no association between fatigue and 
stroke subtype but hypothesized that PSF may be a result from a combination of a 
brain lesion and inappropriate coping with a new life situation after the stroke.15  In 
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2006, Schepers and colleagues examined the relation between fatigue at 1 year post-
stroke and personal characteristics, stroke characteristics, and post-stroke 
impairments.64  The results revealed consistent finding as previous studies11, 15  to 
support that fatigue is not related to lesion side and stroke location. 
Because of the contradicting findings from previous investigations, the 
relationship between the presence of fatigue and stroke lesion side and location is 
unclear.  This dissertation project documented subjects’ lesion side (left versus right) 
and stroke subtypes (ischemic versus hemorrhagic) and included them in the analysis 
as secondary factors. 
 
1.66 Sleep Disorders 
Sleeping problems have been reported in people post-stroke frequently due to 
sleep-related breathing disorders.109  In 2000, Parra and colleagues investigated the 
prevalence and behavior of sleep-related breathing disorders (SRBDs) associated with 
stroke or transient ischemic attack (TIA).  One hundred and sixty-one people post-
stroke in the acute phase were admitted in this study and underwent complete 
neurological assessment.  In this study, stroke subtype was categorized as TIA, 
ischemic (IS), or hemorrhagic (HS).  A portable respiratory recording (PRR) study 
was performed in the acute phase within 48-72 hour after admission and stable phase 
after 3 months.  During the acute phase, 116 patients (71.4%) had an apnea-hypopnea 
index (AHI) > 10 events/h and 45 (28%) had an AHI > 30.  No relationships were 
found between sleep-related respiratory events and the lesion location.  Cheyne-
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Stokes breathing (CSB) was observed in 42 cases (26.1%).  There were no significant 
differences in SRBD according to the stroke subtype.  A second PRR was performed 
during the stable phase in 86 participants: 53 of 86 (61.6%) had an AHI > 10 and 17 
of 86 (19.7%) had an AHI > 30.  The AHI in the stable phase was significantly lower 
than the acute phase while the obstructive apnea index (OAI) remained unchanged.  
CSB was observed in 6 of 86 patients.  These results demonstrated the prevalence of 
SRBD in people with first stroke.  Even though no correlation was found between 
neurological location and the presence or type of SRBD, it is undeniable that SRBD 
can impact the quality of sleep and indirectly contribute to fatigue.  Furthermore, Van 
der Werf and colleagues hypothesized that certain sleep-related breathing problems 
are related to PSF.14  A relation between sleep disorders and PSF is likely to exist due 
to the quality of sleep or oxygen deprivation, which merits further exploration.  In this 
dissertation project, documentation of sleep apnea was included as a secondary factor. 
 
1.67 Medication Side Effects 
A number of medications commonly used in people post-stroke such as β-
blockers, hypnotics, antihypertensives, antihistamines, anticonvulsants, 
corticosteroids, and opiates may lead to fatigue due to side effects.110 
An early study by Dimsdale and Newton examined the effects of atenolol and 
metoprolol on neuropsychologic functioning, mood, sedation, and sleep.  This 
double-blinded study included 35 people with hypertension who randomly received 
either atenolol or metoprolol for 4 weeks. The results did not reveal any significant 
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changes in mood, sedation, or deep sleep as a consequence of treatment with a beta 
blocker; however, there was a trend for a poorer mood profile in subjects who 
received metoprolol.  More importantly, subjects on both medications had substantial 
complaints of fatigue.   
In a recent study to evaluate the relationship between the use of sleep agents 
and quality of life (QOL) in people with cancer,111  909 oncology patients were 
interviewed in clinic setting at three different hospitals.  QOL was measured using the 
European Organisation for Research and Treatment of Cancer Quality of Life 
Questionnaire-C30 (EORTC QLQ-C30) and compared between sleep agent users vs. 
non-users.  Paltiel and colleagues found that 25.7% of subjects use sleeping pill; in 
addition, they found a significant increase of fatigue severity comparing to non-users. 
The authors concluded that the use of sleep agents was associated with substantially 
poorer QOL and increased severity of symptoms. 
Because sleep agents may be commonly prescribed among people post-stroke 
with sleep disorders, it was included in analysis as a secondary factor.  In addition, 
although antidepressants are commonly prescribed among people post-stroke, 
depressive symptoms can still persist under prescription of antidepressants.104  
Antidepressant usage was also included in analysis as a secondary factor in this study. 
 
1.7 Distinction of Experimental Design 
1.71 Visual Analog Fatigue Scale 
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 Previous studies used the generic horizontal version of the visual analog scale 
to measure fatigue.16, 65, 70  However, the validity of data may be questionable due to 
visual field defect, neglect or other visual-perceptual deficits commonly experienced 
among people following stroke.  We developed the Visual Analog Fatigue Scale 
(VAFS) as a vertical scale to assess PSF in order to eliminate subject difficulties and 
poor data validity.  The VAFS is modified from a previously validated vertical 
version of visual analog scale that was designed to assess sleep-related breathing 
disorders in people post-stroke.109 
 
1.72 Real-Time Fatigue Assessment 
Previous studies used the original visual analog scale to measure fatigue over 
a certain time period (e.g. previous 2 weeks),16, 65, 70  This assessment method does 
not allow the scale to be sensitive to EF.  In this dissertation project, the VAFS was 
used to assess the level of fatigue before and after exercise; EF was then calculated 
the as difference between fatigue levels pre-exercise and immediately post-exercise.  
This approach allowed the truthful reflection of EF that was exclusively induced by 
exercise.  In addition, we were able to utilize the VAFS to detect fatigue level at-rest, 
which indicated the type of fatigue that is persistent and chronic in nature.  This real-
time assessment method to detect CF was unique from conventional questionnaire-
based fatigue scales that require subject’s recollection of previous events that could 
have higher subjectivity and variance. 
 
 34
1.8 Significance of the Presented Work 
PSF is a complex phenomenon, and it has been stressed that PSF should be 
recognized, evaluated, monitored, documented, and treated at all stages.18  However, 
conclusive evidence on determinants of PSF is still limited regardless of the previous 
effort.  Very few studies have examined how the potential contributing factors relate 
to PSF using quantifiable outcome measures, and no study has yet to investigate PSF 
by distinguishing EF from CF using outcome measures as potential predictors.  
Difference in the instruments used and the lack of objective physiologic 
measurements of fatigue make it difficult to compare findings measuring fatigue.  It is 
essential to invest more effort to exploring the factors contributing to PSF in order to 
lead the development of future treatment options; this study attempted to fulfill this 
goal by introducing physiologic measures to aid assessing PSF.  This study aimed to 
1) distinguish EF from CF, 2) identify contributing factors of EF and CF in people 
with PSF, and 3) develop a model that is specific to PSF to guide clinicians and future 
research. 
The findings of this study should aid clinicians implement individualized 
therapeutic treatment according to the presence and magnitude of each contributing 
factor.  More specifically, if a physical therapist could detect the contributing 
factor(s) to a person’s post-stroke fatigue, he or she can implement treatments based 
on the nature of such factor(s).  The capability of detecting the types of fatigue also 
helps to pinpoint potential contributing factors.  For example, if EF is observed, it is 
possible that diminished aerobic fitness is the most substantial factor to a person’s 
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PSF.  In this case, aerobic fitness training may be prescribed and incorporated in 
addition to the standard physical therapy treatments.  On the other hand, if a person’s 
PSF is determined to be largely contributed by medication side effects, perhaps 
simply by consulting with the primary physician to alter medication or to reduce 
dosage could help alleviate the fatigue issues.  If depression is detected to be the most 
hindering factor to a person’s PSF, counseling, social outings, and family support 
may be the key solutions to the person’s fatigue issue.  It is important to acknowledge 
the fact that PSF is multidimensional, and so should the treatments.  In addition, the 
findings of this study also contribute to the validity of the multidimensional fatigue 
model in the literature by confirming two of the potential contributing factors. 
 
1.9 Specific Aims and Statement of Hypotheses 
The primary goal of this project was to investigate fatigue issues by 
characterizing the nature of different types of fatigue in people with chronic stroke.  
Two central aims guided this research: 
 
1. Assess predictors of exertion fatigue in people with chronic stroke. (Chapter 3) 
The first aim of this dissertation project was to identify the potential contributing 
factors of exertion fatigue (EF) in people post-stroke using multiple linear regression 
where the response variable is EF and the explanatory variables are aerobic fitness 
(measured by VO2peak), motor control (measured by FMTM), and depressive 
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symptoms (measured by GDS).  It was hypothesized that VO2peak, FMTM score, and 
GDS score will simultaneously predict the presence and severity of EF. 
 
1a. Assess the reliability, responsiveness, and validity of the Visual 
Analog Fatigue Scale in people post-stroke (Chapter 2). 
Due to the lack of adequate instrument to differentiate and to measure 
different types of fatigue, we developed the Visual Analog Exertion Fatigue 
Scale (VAFS) to overcome the inadequacy of measurement method.  The 
VAFS is a clinically feasible tool specifically designed to assess the level of 
exertion or chronic fatigue in people post-stroke.  The research data of this 
dissertation project relied on the validation of the VAFS to measure fatigue 
level in people post-stroke.  Therefore, we assessed the reliability, 
responsiveness, and validity of the VAEFS and found that VAFS is a reliable 
and valid tool to access fatigue in people with chronic stroke. 
 
2. Assess predictors of chronic fatigue in people with chronic stroke. (Chapter 4) 
The second aim of this dissertation project was to identify the potential contributing 
factors of CF in people post-stroke using multiple linear regression where the 
response variables are two CF measures (i.e. VAFSat-rest and FSS) and the explanatory 
variables are aerobic fitness (measured by VO2peak), motor control (measured by 
FMTM), and depressive symptoms (measured by GDS).  It was hypothesized that 
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VO2peak, FMTM score, and GDS score will simultaneously predict the presence and 
severity of CF.   
 
In summary, the research presented in this dissertation contributes to the 
existing body of literature through 3 separate and distinct manuscripts. The first 
manuscript attempts to address the fatigue assessment validity issue in people post-
stroke (Chapter 2, to be submitted to Physical Therapy); the second and third 
manuscripts attempt to differentiate fatigue with different nature and define its 
predictors in people post-stroke (Chapter 3 & 4, to be submitted to Physical Therapy). 
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Figure 1.1 Illustration of Piper’s fatigue model.  We developed this illustration based 
on Piper’s original conceptual framework of fatigue.32 
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Figure 1.2 Illustration of Portenoy’s fatigue model.  We developed this illustration 
based on Portenoy’s integrated fatigue conceptual framework.52 
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Figure 1.3 Illustration of Piper’s dichotomy fatigue concept with duration, onset, and 
recovery rate as key distinctive indicators.  We developed this model based on Piper’s 
dichotomy fatigue concept.53 
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Figure 1.4 Contributing factors to Post-Stroke Fatigue.  We developed this model 
based on the potential fatigue contributing factors specific to people-stroke proposed 
by de Groot et al.20 
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Chapter 2 Preface 
 Chapter 2 is the development of the Visual Analog Fatigue Scale (VAFS) for 
assessing fatigue in people post-stroke. This chapter attempted to address the need for 
a valid assessment tool specifically designed for people post-stroke to quantify 
fatigue.  The work presented in this chapter examined the reliability, responsiveness, 
and validity of the VAFS.  The results suggest that the VAFS is a valid and reliable 
tool to assess fatigue in people post-stroke.  The VAFS was used as the main fatigue 
measurement in Chapter 3 and 4. 
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Chapter 2 
 
 
 
 
 
 
 
 
 
Reliability, Responsiveness and Validity of the Visual Analog Fatigue Scale to 
Measure Exertion Fatigue in People with Chronic Stroke 
 
 
 
 
 
 
 
 
 
To be submitted to Physical Therapy, February, 2009 
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2.1 Abstract 
Background and purpose: Post-stroke fatigue (PSF) is prevalent among survivors of 
stroke; however, it is commonly neglected by health professionals.  To date, defining 
and measuring fatigue has remained a challenge as fatigue is a multifactorial 
phenomena that involves both physiological and psycosocial properties.  The lack of 
understanding and valid measurement may facilitate concealment this overlooked 
public health issue.  To address the inadequacy of assessment methods to measure 
fatigue in people post-stroke, we developed the Visual Analog Fatigue Scale (VAFS).  
Methods: Twenty-one people post-stroke (12 males, 9 female, age = 59.5 ± 10.3 
years; time post-stroke = 4.1 ± 3.5 years) participated in the study.  This experiment 
involved 2 separate visits that were conducted 14 days apart.  The first visit involved 
a 15-minute sub-maximal fatigue-inducing exercise and fatigue assessments using the 
Visual Analog Fatigue Scale (VAFS) at 3 different time points (i.e. at rest, post-
exercise, post-recovery).  Subjects were allowed 15 minutes for recovery.  In 
addition, heart rate (HR), blood pressure (BP), and the Rate of Perceived Exertion 
(RPE) were recorded during exercise.  The second visit consisted of the same 
procedures as the first visit.  Results: Good intra-rater reliability was found for the 
VAFS measures taken during the 2 separate sessions (at rest ICC = 0.851, CI = 95%, 
0.673 ~ 0.936, p < 0.001; immediately after exercise ICC = 0.846, CI = 95%, 0.663 ~ 
0.934, p < 0.001; post-exercise ICC = 0.888, CI = 95%, 0.749 ~ 0.953, p < 0.001).  
Exertion Fatigue (EF) was calculated (VAFSpost-exercise – VAFSat-rest) and increase of 
HR and BP were determined (i.e. HRI and BPI, respectively).  Using Pearson’s 
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correlation coefficient, a significant positive relationship was found for EF and HRI (r 
= 0.738; p = 0.00); EF and SBPI (r = 0.630; p = 0.02); and EF and RPE (r = 0.802; p 
= 0.00).  Conclusion: The results suggest that the VAFS is a valid and reliable tool to 
assess fatigue in people post-stroke. 
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2.2 Introduction 
Post-stroke fatigue (PSF) is a prevalent symptom among survivors of stroke,11, 
14-17, 20, 71, 72  with an incidence rate as high as nearly 70%.11, 64  However, it is a 
commonly neglected issue by clinicians as well as care-givers.11, 14-17  More recently, 
researchers have begun to explore the negative ramifications of PSF on stroke 
rehabilitation.16, 65, 66, 71, 112  For example, survivors of stroke with PSF may have a 
higher fatality rate three years after stroke due to a sedentary lifestyle.15  PSF affects 
performance of daily activities, especially those requiring physical effort,18  which 
may limit participation in a rehabilitation program.  Nevertheless, defining and 
measuring fatigue has remained a challenge as it is a multifactorial phenomena that 
involves both physiological and psycosocial properties.32, 37  
Fatigue has been defined as a feeling of early exhaustion, weariness, lack of 
energy and aversion to effort.17  However, this definition does not distinguish the 
nature of different types of fatigue.  It has been suggested that fatigue can be an 
everyday experience that most individuals report after exertion of physical power or 
use of mental effort.35  Researchers have distinguished this type of fatigue as 
“exertion fatigue” (EF) that is attributed to extensive activities throughout daily 
living.53, 55, 56  Exertion fatigue is acute in nature with a rapid onset and short duration, 
and can be recovered by rest.  On the other hand, “chronic fatigue” (CF) is 
differentiated from EF and is defined as a state of weariness unrelated to previous 
exertion levels that is associated with prolonged stress or pathologies.53, 56  The cause 
of chronic fatigue is uncertain; but several factors may contribute to chronic fatigue 
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such as depressive symptoms,14, 58-60  cancer related treatments,57  and medication 
side-effects.35     
To assess fatigue, many unidimensional27, 34, 57  and multidimensional29, 35, 54, 61  
questionnaires and scales have been developed.  Although it is controversial to 
determine which fatigue scales are the most accurate and appropriate to assess PSF, it 
has been suggested that the appropriateness of a fatigue scale should be determined 
by aspects of fatigue that are being measured.62  It has been proposed that the Dutch 
Exertion Fatigue Scale (DEFS)55  can be used to assess exertion fatigue in patients 
with heart disease, postpartum women, and patients living in a home for the elderly.  
However, it has not been validated in people with chronic stroke.  In a recent study in 
Sweden,71  fatigue was assessed by asking survivors of stroke whether they had 
experienced fatigue and/or pain after the stroke with a yes/no response.  Subjects 
were also asked whether they felt their fatigue was stroke related. This study was able 
to determine the prevalence of PSF; however, it was not able to detect the severity or 
to identify different types of PSF.  In Taiwan, researchers used the Situational Fatigue 
Scale (SFS)54  that specifies the nature and the duration of daily activities to assess 
fatigue in healthy adults.  The results revealed internal consistency and test-retest 
reliability and suggested that the SFS could be a useful tool to measure the broad 
concept of fatigue.  However, several items in the SFS were too specific to the types 
of activity involved and may not applicable to clinical population with physical 
limitations (e.g. playing a ball game for 30 min, jogging for 20 min, or driving for 
1hour).   
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In people post-stroke, the most commonly used scales are the Fatigue Severity 
Scale (FSS)11, 16, 64-66  and the Visual Analog Scale (VAS)16, 65, 70  to assess PSF.  
Choi-Kwan and colleagues16  studied PSF in 220 survivors of stroke using VAS and 
FSS.  They found that 57% of people post-stroke had fatigue problems and concluded 
that PSF is a common complaint among people post-stroke.  In 2006, Michael and 
colleagues65  investigated how mobility, aerobic fitness, and social support are related 
to fatigue in 53 people post-stroke. The severity of fatigue was examined using both 
VAS and FSS.  They found that subjects with higher fatigue scores had lower social 
support and poorer falls efficacy scores than those with less fatigue.  In addition, 
Underwood and colleagues70  examined changes in pain and fatigue in 32 people 
receiving a 2-week constraint-induced movement therapy (CIMT).  Fatigue was 
evaluated using VAS twice daily during therapy.  They concluded that CIMT therapy 
may be administered without exacerbation of pain or fatigue.  Although VAS was 
used to assess PSF in these studies, the reliability and the validity of VAS were not 
reported; and the types of PSF were not identified or differentiated.   
Regardless of all previous effort, there is still a need to validate fatigue 
assessments for people with PSF.113  To the author’s best knowledge, no study has yet 
to differentiate different types of PSF using a simple, reliable and quantifiable 
measure in people with chronic stroke.  We developed the Visual Analog Fatigue 
Scale (VAFS) as a vertical scale to assess PSF.  In this study, a vertical version of 
VAS was utilized in order to eliminate subject difficulties and poor data validity due 
to visual field defect, neglect or other visual-perceptual deficits experienced among 
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people following stroke.  The VAFS is modified from a previously validated vertical 
version of VAS that was designed to assess sleep-related breathing disorders in 
people post-stroke109.  The purpose of this study was to evaluate the reliability, 
responsiveness, and validity of the VAFS to assess PSF in people with chronic stroke 
at rest and following exercise.  We hypothesized that VAFS will show 1) good intra-
rater reliability at rest, immediately post-exercise, and 15-minutes post-exercise; 2) a 
significant effect size of VAFS score change before and immediately after exercise; 
and 3) a direct positive relationship with physiologic measures (i.e. heart rate and 
systolic blood pressure) and the Rate of Perceived Exertion Scale (RPE).68, 69 
 
2.3 Methods 
Experimental Design 
This study used a sample of convenience to determine intra-rater reliability 
and validity of the VAFS in people with chronic stroke. 
 
Participants 
Twenty-one subjects participated in the study.  Individuals were recruited 
from local stroke support groups and the ASTRA (Advancing Stroke Treatment 
through Research Alliances) participant database. To be included in this study, all 
participants must: 1) have a diagnosis of stroke > 6 months and < 5 years ago, 2) have 
the ability to perform the exercise movement on a total body recumbent stepper, 3) 
receive medical clearance from their primary care physician to confirm that subject is 
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medically stable and able to participate in exercise, and 4) score < 2 on a dementia 
screening tool, the AD8.114, 115  Subjects were excluded from the study if they 
presented with any of the following: 
• Hospitalization for myocardial infarction, heart surgery, or congestive heart 
failure during the preceding 3 months. 
• Recent symptoms of chest discomfort. 
• Resting blood pressure of 160/100 or greater. 
• Currently using a pacemaker. 
• Currently smoking or significant pulmonary pathology. 
• Alcoholism or alcohol dependency. 
• Recreational drug use. 
• Medication change within the duration of the study (e.g. antidepressants, 
cardiac medications). 
 
The Human Subjects Committee at the University of Kansas Medical Center 
approved the study.  Institutionally approved informed consent was obtained in 
writing prior to participation in the study. 
 
Procedure 
The first visit involved fatigue-inducing exercise and VAFS at 3 different time 
points.  Prior to the exercise, subjects were presented with the VAFS for the first time 
to measure fatigue at rest (VAFSat-rest1).   Next, subjects were asked to perform a 15-
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minute standardized fatigue-inducing exercise.  During exercise, heart rate, blood 
pressure, and the Rate of Perceived Exertion (RPE)68, 69  were recorded every 5 
minutes.  Immediately followed the exercise, the VAFS was again administered 
(VAFSpost-exercise1).  Subjects were allowed 15 minutes for recovery; then they were 
presented the VAFS for the third time (VAFSpost-recovery1).  A second visit was 
scheduled 14 days after the first visit.  Best effort was given to keep exercise testing 
and data collection at the same or similar time of the day as the first visit.  The actual 
sequence of the second visit was identical to the first visit.  Fatigue scores were 
assessed at rest, immediately after exercise, 15 minutes after exercise (VAFSat-rest2, 
VAFSpost-exercise2, VAFSpost-recovery2, respectively). 
 
Visual Analog Fatigue Scale (VAFS).  Traditionally, a visual analog scale 
VAS82, 116  consists of a 10 cm horizontal line with written descriptions at each end; 
subjects are asked to mark on the line the point that they feel represents their 
perception of their current state (Figure 2.1).  Verbal instruction was given.  Subjects 
were asked by the test administrator “Using the vertical line on the Visual Analog 
Fatigue Scale, please draw a line to indicate how tired you are at this moment.”  The 
possible score ranges from 0 to 100, measured in millimeters on a 10cm vertical line 
using a pen.  The score was obtained by measuring the line from “No Fatigue” to the 
point indicated by the subject that represents their fatigue level; the higher the VAFS 
score, the higher the fatigue.  To avoid bias associated with the position of the text 
description on the VAFS (e.g. top is higher), two different versions were administered 
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in random order.  Version 1 indicated “Very Severe Fatigue” on top of the 10cm line 
and “No Fatigue” below the same vertical line; while version 2 had an opposite 
arrangement to represent the perceptions (Figure 2.1).  The same version of VAFS 
was used at 3 different time points on the same day; subjects who received Version 1 
on the first visit were administered Version 2 on the second visit. 
 
Physiologic Responses.  Heart rate and blood pressure were measured at rest 
and every 5 minutes during exercise.  Heart rate increase (HRI) and systolic blood 
pressure increase (SBPI) were calculated and used for analysis. 
 
Rate of Perceived Exertion (RPE).  The RPE68, 69  was used to determine the 
highest level of effort exerted perceived by subjects.  It was recorded every 5 minutes 
during the fatigue-inducing exercise.   
 
Fatigue-Inducing Exercise. To induce EF, subjects were asked to perform a 
15-minute standardized exercise protocol on a total body recumbent stepper (NuStep, 
Inc; 5111 Venture Drive Suite 1, Ann Arbor, MI 48108).  To standardize the 
workload, all subjects were asked to step at 75 step per minute (SPM) with an 
external power of 75-80 Watts (W) for 15 minutes.  The device and workload of our 
fatigue-inducing protocol was based on the Modified Total Body Recumbent Stepper 
Exercise Test (mTBRS-XT)117 our lab has developed to induce fatigue at a sub-
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maximal level, which allows subjects to become safely fatigued at 40-70% of 
VO2Max.118 
 
Data Analysis 
SPSS 15.0 (SPSS, Inc; 233 S. Wacker Drive 11th Floor Chicago, IL 60606) 
statistical software was used to perform all statistical analysis; alpha level of 0.05 was 
used to determine statistical significance.  Descriptive statistics were calculated.  EF 
was calculated by subtracting VAFSat-rest score from VAFSpost-exercise score (VAFSpost-
exercise – VAFSat-rest).  Recovery Rate (RR) was calculated as the percentage using this 
formula: (VAFSpost-exercise – VAFSpost-recovery) / (VAFSpost-exercise – VAFSat-rest) x 100.   
 
Intra-rater Reliability.  To determine intra-rater reliability, the intraclass 
correlation coefficient (ICC3,1) was calculated for all appropriate pairs of repeated 
measure taken during Visits 1 and 2 (i.e. VAFSat-rest1 vs VAFSat-rest2, VAFSpost-exercise1 
vs VAFSpost-exercise2, VAFSpost-recovery1 vs VAFSpost-recovery2, EF1 vs EF2, and RR1 vs 
RR2).  Bland-Altman plot was used to examine the shift in the measurement and the 
variability in the VAFS change score. 
 
Responsiveness.  To examine the ability of the VAFS to detect change over 
time, the Effect size (ES) was calculated as an index of responsiveness using the 
formula ES = mean (VAFSpost-exercise – VAFSat-rest) / standard deviation VAFSpost-
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exercise.119  In addition, paired t-test was used to determine difference between scores 
at-rest and post-exercise, and between post-exercise and post-recovery. 
 
Validity.  The peak RPE values were used for analysis; heart rate increase 
(HRI) and systolic blood pressure increase (SBPI) were calculated by subtracting 
respective values at rest from the peak values during the exercise.  Pearson’s 
correlation coefficient was used to determine the relationship between EF and HRI, 
EF and SBPI, and EF and RPE. 
 
2.4 Results 
Characteristics of the 21 subjects are shown in Table 2.1.  One subject was 
only able to complete 5 minutes of the 15-mminute fatigue-inducing protocol and 
requested early termination due to fatigue and shortness of breath in both visits.  
Although subject reported high level of exertion fatigue, no chest pain and any 
adverse event was observed. 
 
Reliability of the VAFS  
Good120  intra-rater reliability was found for the VAFS measures taken during 
the 2 separate sessions. ICC values for the VAFS at rest was 0.851 (CI = 95%, 0.673 
~ 0.936, p < 0.001), immediately after exercise was 0.846 (CI = 95%, 0.663 ~ 0.934, 
p < 0.001), and 15 minutes after exercise was 0.888 (CI = 95%, 0.749 ~ 0.953, p < 
0.001) as shown in Table 2.2.  The VAFS measures of both visits are illustrated in 
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Figure 2.2; the Bland-Altman plot in Figure 2.3 illustrates the presence of a shift in 
the VAFS measure at rest, with relatively low variability.  In addition, the Intra-rater 
reliability for the EF and the RR was also good120  with the ICC values of 0.829 (CI = 
95%, 0.631 ~ 0.927, p < 0.001) and 0.893 (CI = 95%, 0.760 ~ 0.955, p < 0.001), 
respectively. 
 
Responsiveness 
The ES values for at-rest to post-exercise and for post-exercise to post-
recovery were 14.512 and 0.685, respectively.  A large ES was found for the change 
in VAFS scores between at rest and immediately post exercise; and a moderate ES 
was found for the change between immediately post exercise and post recovery.119  
Using the paired t-test, significant difference was found between VAFS scores at-rest 
and post-exercise (p < 0.001), and between post-exercise and post-recovery (p < 
0.001). 
  
Validity Testing 
HR Increase was 41.1 (± 14.9) beats per minute; SBP Increase was 37.1 (± 
14.0) mmHg; and the RPE was 15.8 (± 2.9).  A significant positive relationship was 
found using Pearson’s correlation coefficient for EF and HRI (r = 0.738; p = 0.00); 
EF and SBPI (r = 0.630; p = 0.02); and EF and RPE (r = 0.802; p = 0.00).  The 
relationship between the EF, HR, and SBP are illustrated in Figure 2.4 and 2.5, 
respectively. 
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2.5 Discussion 
Our data demonstrated good intra-rater reliability of the VAFS at rest, 
immediately after exercise, and 15 minutes post-exercise.  This finding supports our 
first hypothesis that the VAFS is a reliable instrument to assess PSF in people post-
stroke.  The VAFS also demonstrated good intra-rater reliability to measure exertion 
fatigue (EF) and recovery rate (RR).  The VAS is commonly used to measure pain in 
clinical studies.  For example, a study that examined the validity and reliability of the 
VAS in measuring acute abdominal pain found high reliability with ICC values of 
0.990.121  This finding is consistent with our study to suggest good intra-rater 
reliability for the measures taken at separate times.  However, several fatigue studies 
that utilized the original VAS to assess PSF did not establish reliability or validity and 
used a simple measure to describe a complicated, poorly-defined phenomenon.16, 65, 70   
Strohschein and colleagues evaluated the validity and reliability of the Piper 
Fatigue Scale in 64 post-polio patients.122  Subjects were asked to complete the Piper 
Fatigue Scale and the Chalder Fatigue Questionnaire.  Convergent validity was shown 
with a strong positive correlation between Piper Fatigue Scale scores and Chalder 
Fatigue Questionnaire scores (r = 0.80; n= 46). Reliability was also demonstrated 
with the Piper Fatigue Scale's strong Intra-rater reliability with ICC value of  0.98 (n 
= 20).  The authors concluded that the Piper Fatigue Scale is a valid and reliable tool 
for measuring fatigue in post-polio patients.  
In 2003, Michelson and colleagues examined the Fatigue Assessment Scale 
(FAS), a 10-item fatigue measure, in 351 adults and found  a high internal 
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consistency and reliability (ICC = 0.77).27  The authors conluded that the FAS is a 
potentially valuable assessment instrument with promising internal consistency 
reliability and validity.  
Although previous fatigue scales reported good reliability and ICC values,27, 
122  these scales were not designed to measure EF and did not examine the 
responsiveness to change of fatigue level.  In order to accurately measure EF, the 
VAFS must be administered at the appropriate time; and to calculate EF, values need 
to be determined by subtracting the VAFS score at baseline from the score assessed 
immediately after exercise.  
The VAFS demonstrated large responsiveness to changes between at rest and 
immediately after exercise, and moderate responsiveness between immediately after 
exercise and 15 minutes post-exercise, as determined by the ES.  An ES value of 0.4 
is considered small, 0.5 is considered moderate, and 0.8 and greater is viewed as 
large.119  Our analysis was designed to examine the ability of the VAFS to detect 
immediate change of fatigue level due to exercise over a short period of time; changes 
of long-term fatigue level due to exercise training effect over a prolonged time period 
was not intended  as part of our analyses. 
Our data showed a significant positive relationship between the fatigue 
induced by exercise (measured by EF) and physiologic responses (i.e. hear rate and 
blood pressure, measured by HRI and SBPI, respectively).  We also found a 
significant positive relationship between EF and subjectively perceived level of 
exertion (measured by RPE).  The RPE and VAFS measure different constructs, as 
 58
the RPE reflects the perceived level of exertion during exercise, not the level of 
exertion fatigue after exercise.  In addition, by using VAFS, subjects are required to 
base their answers on intuitive response at the moment, which may help avoid 
recollections of previous references that are verbal or numerical.  These findings 
indicate that VAFS is a valid instrument to measure fatigue following exercise in 
people with chronic stroke.   
Consistent with the findings of Choi-Kwan and colleagues,16  we found a high 
prevalence of fatigue in people post-stroke.  Using the VAFS, we found evidence of 
baseline fatigue (Appendix I) in most subjects (20 out of 21) at rest prior to fatigue-
inducing exercise.  This discovery indicates that this type of baseline fatigue can exist 
independently of physical stress, which supports previous findings15  to suggest a 
distinct construct in PSF that is persistent and chronic in nature.  In 2002, Glader and 
colleagues conducted a follow-up study to investigate PSF in people 2 year post-
stroke and concluded that PSF is frequent and can be persistent and chronic even late 
after stroke.15   
 One of the limitations in this study is the small sample size.  Compared to 
other studies of scale development,27, 57, 122  this study reported data based on a 
relatively small sample size.  Although statistical significance was achieved, we were 
not able to do subgroup analyses to determine whether reliability and validity of 
VAFS would be different between gender, different types of stroke, and different 
times post stroke.  We were unable to establish normative values of the VAFS in 
healthy populations due to the limited sample size.  We acknowledge the absence of 
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these comparison values as a limitation.  Future studies may consider assessing 
fatigue using the VAFS in both young and older healthy adults. 
Although baseline fatigued was detected, this study was not designed to 
distinguish other types of fatigue such as chronic fatigue or circadian fatigue (Appendix 
I).  Future studies may consider measuring fatigue at different times of the day in 
order to detect such matters.  Our data suggests two distinct constructs of PSF that are 
unique in nature; we also recommend that other types of fatigue measures could be 
used in future studies to detect other types of fatigue besides EF (e.g. chronic fatigue).  
Finally, future studies need to identify predictors of PSF in order to address fatigue 
issues with an intervention in people post-stroke. 
 
2.6 Conclusion 
In conclusion, the reliability, responsiveness, and validity of the Visual 
Analog Fatigue Scale (VAFS) appear to be promising when used to assess exertion 
fatigue in people with chronic stroke. 
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Figure 2.1 Illustration of (A) traditional visual analog scale used to measure pain, (B) 
VAFS Version 1, and (C) VAFS Version 2. 
VAFS – Visual Analog Fatigue Scale 
 
 (A) 
 
(B)                   (C) 
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Figure 2.2 VAFS measures at-rest, post-exercise, and post-recovery from Visit 1 & 2. 
VAFS – Visual Analog Fatigue Scale 
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Figure 2.3 Bland-Altman plot of the VAFS scores at-rest from Visit 1 & 2 indicates 
no shift and low variability. 
VAFS – Visual Analog Fatigue Scale 
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Figure 2.4 Scatterplot illustrating the relationship between EF and HR Increase. 
EF – Exertion Fatigue 
HR – Heart rate 
BPM – beats per minute 
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Figure 2.5 Scatterplot illustrating the relationship between EF and SBP Increase. 
EF – Exertion Fatigue 
SBP – Systolic Blood Pressure 
mmHg – Millimeter of mercury 
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Table 2.1 Participant characteristics (n = 21). Values are means + SD. 
Characteristics     Values 
Men / women      12 / 9     
Stroke lesion side: right / left / brain stem  15 / 4 / 2 
Stroke subtype: ischemic / hemorrhagic  18 / 3  
Age (years)      59.5 ± 10.3 
Time post-stroke (years)    4.1 ± 3.5 
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Table 2.2 The Intraclass Correlation Coefficient of measures on 2 separate visits (n = 
21). 
 
 Visit 1 Visit 2 ICC 
VAFSat-rest 7.2 ± 4.3 8.3 ± 4.5 0.851 
VAFSpost-exercise 69.4 ± 30.5 65.8 ± 31.9 0.846 
VAFSpost-recovery 48.5 ± 25.4 47.5 ± 26.9 0.888 
EF 62.4 ± 29.3 57.5 ± 30.9 0.829 
RR (%) 37.0 ± 17.3 37.7 ± 15.9 0.893 
 
VAFS – Visual Analog Fatigue Scale 
EF – Exertion Fatigue (EF = VAFSpost-exercise – VAFSat-rest) 
RR – Recovery Rate (RR = VAFSpost-exercise – VAFSpost-recovery) / (VAFSpost-exercise – 
VAFSat-rest) x 100 
ICC – Intraclass correlation coefficient, model (3,1) 
P – Probability Value 
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Chapter 3 Preface 
 Chapter 2 examined the reliability and validity of the Visual Analog Fatigue 
Scale (VAFS). We found that the VAFS is a valid and reliable tool to assess fatigue 
in people post-stroke. 
In Chapter 3, we examined the Exertion Fatigue (EF) regression model using 
EF as the response variable (measured by the VAFS), and aerobic fitness, motor 
control and depression as explanatory variables (measured by VO2peak, Fugl-Meyer 
total motor, and Geriatric Depression Scale, respectively).  We found that aerobic 
fitness was a good predictor for EF.  
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Chapter 3 
 
 
 
 
 
 
 
 
 
Predictors of Exertion Fatigue in People Post-Stroke 
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3.1 Abstract 
Background and purpose: Post-Stroke Fatigue (PSF) is a commonly neglected issue 
despite the high incidence rate reported in people post-stroke.  It can impact daily 
functions and quality of life and has been linked with a higher mortality rate after 
stroke because of its association with sedentary lifestyle.  Previous studies have 
identified exertion fatigue (EF) but have not distinguished its contributing factors 
using quantifiable outcome measures as predictors that are specific to PSF.  
Methods: Twenty-one people post-stroke (12 males, 9 female, age = 59.5 ± 10.3 
years; time post-stroke = 4.1 ± 3.5 years) participated in the study.  At rest, 
participants were asked to report their level of fatigue using the Visual Analog 
Fatigue Scale (VAFS).  Next, they underwent a standardized fatigue-inducing 
exercise on a recumbent stepper.  Immediately after the exercise, the VAFS was 
administered again to assess the level of fatigue at the moment.  Exertion fatigue (EF) 
was calculated by subtracting the VAFS score at-rest from the VAFS score post-
exercise.  The explanatory variables included aerobic fitness, motor control, and 
depressive symptoms measured by VO2peak, Fugl-Meyer total motor (FMTM) scores, 
and Geriatric Depression Scale (GDS), respectively.  Results: Using stepwise 
multiple regression, we found that that VO2peak was an independent predictor of EF (p 
= .006) and explained 30.5% of variance in EF (adjusted R2 = .305).  Conclusion: We 
found that aerobic fitness is a strong independent predictor of EF in people post-
stroke with PSF.  In addition, the VAFS also detected fatigue prior to exercise that 
was independent of activities involved.  It is important to acknowledge that EF a 
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unique construct of PSF that differs from other types of fatigue that are persistent or 
chronic in nature. 
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3.2 Introduction 
Following a stroke, the incidence of post-stroke fatigue (PSF) has been 
reported to be as high as 76% 8 months after stroke,123  and can persist in 75% of 
people even 26 months after stroke.124  PSF affects performance of daily activities18  
and is associated with other negative ramifications such as poor quality of life66  and 
higher fatality rate.15 
A recent review study highlighted the scarcity of interventions directed at 
PSF, and concluded that there is a need to identify people most likely to experience 
PSF, to validate existing fatigue assessments, and to evaluate the efficacy of fatigue 
treatment in survivors of stroke.113  However, before any effective countermeasure of 
PSF can be developed and implemented, it is essential to first identify the nature of 
PSF and its potential contributing factors. 
Fatigue is difficult to define and measure.37  Although it has been described as 
a feeling of early exhaustion, weariness, lack of energy and aversion to effort,17  this 
definition does not distinguish the nature of different types of fatigue.  Some have 
suggested that fatigue can be an everyday experience that most individuals report 
after exertion of physical power or use of mental effort.35  Researchers have 
distinguished this type of fatigue as “exertion fatigue” (EF) that is attributed to 
extensive activities throughout daily living.36, 55  The difference between fatigue and 
EF is that fatigue doe not necessarily have a relationship with the performing of 
activities; while EF is directly related to activities.36  Exertion fatigue is acute in 
nature with a rapid onset and short duration, and can be recovered by rest. 
 72
In 1998, Tiesinga and colleagues followed up with their earlier investigation 
and developed the Dutch Fatigue Scale (DUFS) and Dutch Exertion Fatigue Scale 
(DEFS) to assess general fatigue and EF, respectively.55    They tested the DEFS in 
138 patients with chronic heart failure and suggested that the DEFS is a reliable, 
valid, and strong instrument to measure EF in clinical setting.  The DEFS is a 9-item 
questionnaire with scores ranges from 0-36; each item is specific to an activity (e.g. 
walk for 30 minutes), however, some items lacked clarity of the intensity and 
duration of task described (e.g. shopping, take a shower standing).  Although it has 
been suggested that the DEFS can be used to in different clinical populations such as 
patients with heart disease and women that are postpartum, it has not been validated 
in people with chronic stroke and does not involve real-time measures.  Nonetheless, 
Tiesinga and colleagues pioneered a clinically feasible assessment and the conceptual 
groundwork for EF. 
In 2003, de Groot and colleagues conducted a review study to address PSF 
and suggested several potential contributing factors specific to PSF.20  Some of the 
physiologic factors include: immobility or inactivity such as physical impairment, 
deconditioning, and disuse; sleep disorders such as sleep apnea or insomnia; and 
medication side effects.  Some of the psychologic factors include: depression, 
cognitive impairment, and altered levels of perceived effort.  In this study, we 
examined three variables that are considered substantial contributors to PSF in 
previous investigations - aerobic fitness,18, 20, 65  physical impairment,14, 15, 20, 65  and 
depression.11, 14-16, 20 
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People post-stroke have diminished aerobic fitness.10, 45, 77, 79  Previous studies 
have assessed the peak oxygen uptake (VO2peak) of stroke survivors77, 79 and reported 
low peak VO2 levels (13 ml/kg/min ~ 16 ml/kg/min) among people post-stroke, 
which is only 50% of healthy older adults.  A comparable reduction was reported in 
maximal walking velocity (1.02+/-0.28m/s) and endurance (294.1+/-120.2m) by 
conducting a six-minute-walk test.78, 80  Aerobic exercise has been shown to increase 
aerobic fitness after stroke,77, 78  and its effects on PSF is a subject worthy of study.  
More specifically, when studying EF, it is important to acknowledge the potential role 
of aerobic fitness.  In this study, VO2peak was assessed as a potential predictor of EF 
using a maximal effort graded exercise test on a total body recumbent stepper.83 
People post-stroke often experience increased energy expenditure due to 
limitations such as decreased range of motion, muscle tone, mal-alignment, and other 
musculoskeletal problems, which lead to poor biomechanical efficiency (e.g. 
inadequate gait due to the inability to activate normal motor patterns).78  Researchers 
have considered physical impairment as a contributing factor to PSF.14, 16, 20, 65, 66  In 
2006, Appelros et al examined pain and fatigue in 253 survivors of stroke at baseline 
and 1 year post-stroke and documented the general characteristics of the patients, 
stroke type, stroke severity and risk factors at baseline.71  Fatigue was assessed by 
asking the subjects whether they had experienced fatigue which had started after the 
stroke.  After 1 year survivors were examined with respect to residual impairment, 
disability, cognition and depression.  Appelros found that fatigue was associated with 
physical disability and sleep disturbances.  In this study, physical impairment was 
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assessed using the FM total motor score (FMTM), which consisted of the combined 
scores from the upper extremity (UE) and the lower extremity (LE) portions of the 
FM test.93   
In people post-stroke, depression is the only identified factor with a significant 
relation to PSF.14, 17, 59  Nevertheless, fatigue can exist independently of depression.11, 
14-16  A mail-survey study in 2005 evaluated the characteristics of and the factors 
associated with PSF in 220 people post-stroke.16  Choi-Kwan and colleagues reported 
that 57% of 220 people 15 months post-stroke had fatigue problems and 24% had 
post-stroke depression.  In addition, 50% of the people without post-stroke depression 
also post-stroke fatigue.  The authors concluded that fatigue is a common complaint 
among people post-stroke, and it can be independent of depression.  Previous 
researchers have suggested that depression and depressive symptoms should be 
observed66  while acknowledging other factors may also play a role in contributing 
PSF.64  In this study, depression was assessed as a potential predictor of EF using the 
Geriatric Depression Scale (GDS).74  
Scales have been developed to measure EF in patients with chronic heart 
failure, postpartum women, and patients living in a home for the elderly,55  however, 
these measures have not been validated in people with chronic stroke.  The most 
commonly used scales to assess PSF are the Fatigue Severity Scale (FSS)11, 16, 64-66  
and the Visual Analog Scale (VAS).16, 65, 70  However, none of the previous studies 
described PSF by differentiating EF from other types of fatigue.  We have developed 
the Visual Analog Fatigue Scale (VAFS) specifically for survivors of stroke to assess 
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EF and found good reliability, responsiveness, and validity (Chapter 2).  Yet, the 
potential contributing factors of EF following stroke remain undetermined.  To the 
author’s best knowledge, no study has yet identified predictors of EF in people post-
stroke using quantifiable outcome measures as predictors. 
The purpose of this study was to identify the potential contributing factors of 
EF in people post-stroke using multiple linear regression where the response variable 
is EF and the explanatory variables are aerobic fitness (measured by VO2peak), motor 
control (measured by FMTM), and depressive symptoms (measured by GDS).   
 
3.3 Methods 
Experimental Design 
This study used a convenience sample and a cross-sectional design to 
determine the predictors of EF in people post-stroke using aerobic fitness, motor 
control, and depressive symptoms as potential contributing factors. 
 
Participants 
Twelve men and 9 women (59.5 ± 10.3 years, 4.1 ± 3.5 years post-stroke) 
participated in the study.  Individuals were recruited from local stroke support groups 
and the ASTRA (Advancing Stroke Treatment through Research Alliances) 
participant database. To be included in this study, all participants must: 1) have a 
diagnosis of stroke > 6 months and < 5 years ago, 2) have the ability to perform the 
exercise movement on a total body recumbent stepper, 3) receive medical clearance 
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from their primary care physician to confirm that subject is medically stable and able 
to participate in exercise, and 4) score < 2 on a dementia screening tool, the AD8.114, 
115  Subjects were excluded from the study if they presented with any of the 
following: 
• Hospitalization for myocardial infarction, heart surgery, or congestive heart 
failure during the preceding 3 months. 
• Recent symptoms of chest discomfort. 
• Resting blood pressure of 160/100 or greater. 
• Currently using a pacemaker. 
• Currently smoking or significant pulmonary pathology. 
• Alcoholism or alcohol dependency. 
• Recreational drug use. 
• Medication change within the duration of the study (e.g. antidepressants, 
cardiac medications). 
 
The Human Subjects Committee at the University of Kansas Medical Center 
approved the study.  Institutionally approved informed consent was obtained in 
writing prior to participation in the study. 
 
Procedure 
The experiment consisted of 2 visits. One visit involved assessment of 
exertion fatigue, a fatigue-inducing exercise, level of motor control and depressive 
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symptoms. The other visit involved an assessment of the peak oxygen uptake using a 
calibrated total body recumbent stepper (NuStep, Inc; 5111 Venture Drive Suite 1, 
Ann Arbor, MI 48108).  The 2 visits were scheduled 24-48 hours apart to allow 
recovery. 
 
Assessment of Exertion Fatigue (EF).  Visual Analog Fatigue Scale (VAFS) 
was used to assess the level of EF.  The VAFS consists of possible score ranges from 
0 to 100, measured in millimeters on a 10cm vertical line using a pen.  Verbal 
instruction was given.  Subjects were asked by the test administrator “Using the 
vertical line on the Visual Analog Fatigue Scale, please draw a line to indicate how 
tired you are at this moment.”  The score was obtained by measuring the line from 
“No Fatigue” to the point indicated by the subject that represents their fatigue level.  
The VAFS has been reported to have good reliability, responsiveness, and validity 
(Chapter 2).  Subjects were presented the VAFS for the first time to measure fatigue 
at rest (VAFSat-rest).  Immediately followed a 15-minute standardized fatigue-inducing 
exercise, the VAFS was again administered (VAFSpost-exercise).  Subjects were allowed 
15 minutes for recovery; then they were presented the VAFS for the third time 
(VAFSpost-recovery).  EF was calculated by subtracting VAFSat-rest score from VAFSpost-
exercise score (VAFSpost-exercise – VAFSat-rest).  In addition, Recovery Rate (RR)  was 
calculated as the percentage using this formula: (VAFSpost-exercise – VAFSpost-recovery) / 
(VAFSpost-exercise – VAFSat-rest) x 100. 
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Standardized Fatigue-Inducing Exercise.  To induce EF, subjects were asked 
to perform a 15-minute standardized exercise protocol on a total body recumbent 
stepper.  To standardize the workload, all subjects were asked to step at 75 step per 
minute (SPM) with an external power of 75-80 Watts (W) for 15 minutes.  In this 
study, the device and workload of the fatigue-inducing protocol was chosen to allow 
subjects to become safely fatigued at 40-70% of VO2Max.118 
 
Aerobic Fitness (VO2peak).  To assess aerobic fitness, a maximal effort graded 
exercise test was conducted using a calibrated metabolic cart and the mTBRS-XT 
protocol our lab has developed specifically for people post-stroke.83  Subjects were 
asked to refrain from eating food for an hour and drinking caffeine for 2 hours prior 
to the test.  According to the test protocol, subjects stepped at 80 steps-per-minute 
(SPM) with a gradually increasing level of resistance.  A cool-down period of 4 
minutes followed the end of the test.  Each subject’s ECG was monitored by a 12-lead 
ECG system during the exercise test.  The exercise test was terminated using the 
following criteria: (1) the participant reached volitional fatigue and requested to end 
the test, (2) the participant’s VO2peak plateaued or decreased despite continuation of 
exercise, (3) the participant was unable to maintain the cadence, or (4) an adverse 
cardiovascular event or response to the exercise test was observed.  The successful 
completion of the maximal effort graded exercise test (measured in VO2max) was 
determined by reaching 1) the predicted maximal heart rate [(220-age), 2) the 
respiratory exchange ratio (RER > 1.1), and 3) plateau of VO2 values despite 
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continuation of exercise.118  When the subjects were unable to achieve their maximal 
effort, the aerobic fitness level at the peak values were collected (measured in 
VO2peak).  
Fugl-Meyer (FM).  The FM was used to determine the level of motor function 
in the hemiparetic limbs following stroke.  The FM is a reliable and valid tool that 
was specifically designed as a clinical measure of sensorimotor impairment for 
stroke.93  The total possible score is 124, which consists of sensation (FMSEN - 24), 
upper extremity (FMUE - 66), and lower extremity (FMLE - 34).  Because the 
fatigue-inducing exercise in this study required motor performance of all four limbs, 
the combined total motor (FMTM) scores of the FMUE and FMLE were determined 
(FMTM = FMUE + FMLE)95  and used for analyses. 
 
Geriatric Depression Scale (GDS).   The GDS is a questionnaire that includes 
30 items that refer to affective, cognitive, and behavioral symptoms of depression to 
assess mood.  It has been tested and used extensively with the older population with 
good validity and reliability.74, 125  The possible score ranges from 0 to 30. 
 
Data Analysis 
SPSS 16.0 (SPSS, Inc; 233 S. Wacker Drive 11th Floor Chicago, IL 60606) 
statistical software was used to perform all statistical analysis.  Descriptive statistics 
were calculated.  Histograms for each variable were analyzed for normal distributions, 
and scatterplots were analyzed for outlying scores.  A stepwise linear regression 
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model with 3 predictors (VO2peak, FMTM, and GDS scores) was calculated for 
exertion fatigue (EF).  Correlations among variables were calculated with the Pearson 
correlation coefficient.  The validity of each model was assessed through analysis of 
colinearity statistics (variance inflation factor) and Q-Q plots of unstandardized 
residuals.  In addition, secondary analysis using Pearson’s correlation coefficient was 
performed in order to explore the relationship between exertion fatigue (EF) and 
recovery rate (RR) after exercise, and between recovery rate (RR) and aerobic fitness 
(VO2Peak).  A 0.05 level of significance was used for all statistical tests. 
 
Sample Size 
Initially, it was proposed that 30 subjects with chronic stroke will be recruited.  
In order to maximize limited resources and to avoid over-recruitment of subjects, a 
planned interim analysis was conducted after the completion of data collection for 20 
subjects. The goal of this analysis was to determine whether further recruitment is 
required in order to satisfy statistical significance.  To reduce the chance of making a 
type I error, alpha level was set at 0.01 for the interim analysis. 
Power calculations indicated that for the interim analysis, the twenty subjects 
had 70% power to detect explanatory variables in a multiple linear regression (with 
three explanatory variables) with an R-square of 0.27 or greater and have 80% power 
to detect explanatory variables with an R-square of 0.31 or greater.  These 
calculations used were done at the alpha = 0.01 level, as we conducted an interim 
analysis after twenty subjects (nQuery Advisor 6.01, 1995-2005). 
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3.4 Results 
Data was collected from 21 individuals with chronic stroke; 5 out of 21 
subjects were able to reach their maximal effort (measured by VO2max); while the 
other 16 subjects reached their peak effort (measured by VO2peak) according to our 
termination criteria.  The 5 subjects who reached maximal oxygen uptake had VO2 
values that ranged from 19.0 ml/kg/min to 33.1 ml/kg/min, which were higher than 
the group mean of 16.2 ml/kg/min.  Out of 21 subjects, 1 subject was only able to 
complete 5 minutes of the 15-mminute fatigue-inducing protocol and requested early 
termination due to fatigue and shortness of breath in both visits.  Although subject 
reported high level of exertion fatigue, no chest pain and any adverse event was 
observed.  Subject characteristics are shown in Table 3.1.  Descriptive statistics of all 
variables are shown in Table 3.2 and correlations among variables are shown in Table 
3.3. 
Using stepwise linear regression, we found the regression model for the EF 
with 3 variables (VO2peak, FMTM, and GDS scores) was statistically significant, with 
VO2peak as a significant individual factor that explained 30.5% of variance in EF.  The 
result of this model is presented in Table 3.4.  Using Pearson’s correlation coefficient, 
significant correlations were found for RR and EF (r = -0.649; p = 0.001) and for RR 
and VO2Peak (r = 0.891; p < 0.000), as shown in Figure 3.1 and 3.2, respectively. 
 
3.5 Discussion 
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Our data suggests that VO2peak is a significant individual predictor for 
Exertion Fatigue (EF); previous research was unable to reach this conclusion.65  In 
2006, Michael and colleagues investigated how aerobic fitness, mobility deficit, 
ambulatory activity, self-efficacy for falls, and social support are related to fatigue in 
53 people post-stroke.65  The severity of fatigue was examined using Fatigue Severity 
Scale (FSS)34  and the Visual Analog Scale (VAS);82  aerobic fitness was assessed at 
the peak level using a graded exercise protocol on a treadmill.  In addition, timed 10-
meter walks, the Berg Balance Scale, total daily step activity, the Medical Outcomes 
Study Social Support Survey, and the Falls Efficacy Scale were also administered.  
They found that 46% of people post-stroke had severe fatigue; fatigue showed an 
inverse relationship with falls efficacy and social support, but not with aerobic fitness 
or ambulatory activity. 
Although Michael and colleagues used the VAS that is similar to our VAFS to 
assess fatigue, the timing the VAS assessment was not specific to exercise.  Rather, it 
was a single-time-point assessment that measured “overall” fatigue severity of the 
testing day.  This type of fatigue assessment can only represent general level of 
fatigue, but not the type of fatigue that is activity-related such as EF.  In our study, the 
VAFS was administered before and after the fatigue-inducing protocol; and the EF 
was calculated by subtracting VAFSat-rest score from VAFSpost-exercise score (VAFSpost-
exercise – VAFSat-rest).  This method ensured that the fatigue being measured was valid 
and was solely attributed to the exercise given that challenged subject’s aerobic 
fitness capacity. 
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In addition to the VAS, Michael and colleagues used the FSS to detect fatigue.  
Although the FSS has been previously established and used in several PSF studies,11, 
16, 64-66  it focuses on functional effect of fatigue over the previous week, which is 
chronic in nature.  The FSS was not sensitive enough to detect the type of fatigue that 
is associated with real-time exertion (e.g. exercise, household activity, or social 
activities).  Furthermore, Michael and colleagues used a treadmill to access peak 
oxygen uptake; the current study used the mTBRS-XT protocol83  on a total body 
recumbent stepper.  These discrepancies in testing methods may contribute to the 
contradicting findings between current and previous investigations. 
Since approximately 76% of our subjects did not reach their maximal aerobic 
fitness capacity, the results should be interpreted with caution.  Theoretically, if we 
were able to obtain VO2max instead of VO2peak from all subjects, we would likely 
report higher VO2 values for those who didn’t reach VO2max as VO2peak is an 
underestimation of the actual maximal values.  It is our postulation that VO2max would 
better predict EF than VO2peak if it was used as one of the explanatory variables in our 
regression model,  In that regard, the literature has shown that aerobic exercise can 
increase aerobic fitness in people post-stroke,77, 78  and its effects on PSF merits 
further investigations. 
Although previous researchers considered physical impairment as a 
contributing factor to PSF,20, 71  we did not find that motor control ability in the 
hemiparetic limbs as an independent predictor of EF in this study.  Although our 
fatigue-inducing protocol involved all 4 limbs, it is probable that our exercise did not 
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challenge full motor control capability as it was performed on a total body recumbent 
stepper.  Future studies may consider administering fatigue-inducing protocol that is 
task-specific and requires full range of motion and coordination of hemiparetic limbs 
such as mimicking cooking activities while standing in front of a simulated kitchen 
counter.  This approach will further induce EF to a higher degree and may better 
capture the poor biomechanical efficiency and increased energy expenditure due to 
limited range of motion, muscle tone, and mal-alignment often experienced in people 
post-stroke.  In addition, future studies may consider incorporating muscular 
endurance and strength measures (e.g. isokinetic device) in the regression model to 
describe EF instead of motor control measured by FM.  Although some researchers 
have used FM as an indication of stroke severity or impairment;95-97  muscular 
endurance and strength measures are direct measures of muscular properties and 
could perhaps describe EF more truthfully than FM. 
We did not find depression as an independent predictor of EF in this study.  
This finding conflicts with previous research that suggested that depression is a 
significant factor relating to PSF in survivors of stroke.64, 66  It has been suggested 
that fatigue and major depressive disorder are often comorbid with each other and are 
commonly associated with other psychiatric disorders such as increased risk for 
suicide; barriers to treatment such as treatment resistance; and medical conditions 
such as cardiovascular disease and diabetes mellitus.104  Interestingly, some 
researchers also suggested that fatigue can also exist independently of depression.11, 
14-16  In this study, we used the VAFS to measure fatigue that is associated with 
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exertion, which is different from the type of fatigue measured by the FSS in previous 
studies.64, 66 
In addition, we found a positive relationship between aerobic fitness and 
recovery rate (RR); and a negative relationship between EF and RR.  In other words, 
the better the aerobic fitness, the better the recovery after exercise; and the better the 
recovery, the lesser the fatigue experienced after exercise.  This finding is comparable 
to Piper’s dichotomy fatigue concept,53  which differentiates acute and chronic fatigue  
based on duration of fatigue symptoms, onset of fatigue, and the recovery rate.53 
Unfortunately, we were unable to compare the RR data collected from our study with 
other populations due to the fact that no previous study has used real-time fatigue 
assessment to calculate recovery rate as we attempted.  Nevertheless, a similar 
assessment of heart rate recovery (HRR) has been well documented in both healthy  
adults126-128  and adults with coronary artery disease.129-132 
HRR within the first few minutes of graded exercise has been associated with 
impaired clinical outcomes in people with coronary artery disease.129  Abnormal HRR 
is defined as < 12 beats/min for standard exercise testing, which may be a reflection 
of decreased vagal activity.  Abnormal HRR is also a powerful predictor of overall 
mortality, independent of workload, the presence or absence of myocardial perfusion 
defects, and changes in heart rate during exercise.129  In addition, HHR has been 
shown to have the same predictive power even after sub-maximal exercise.126  
Previous studies monitor HRR from 1 to 2 minutes post-exercise;126-132  in our study, 
we allowed subjects 15 minutes to recovery from the standardized fatigue-inducing 
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exercise.  Although the recovery time of our protocol was substantially longer, HRR 
does not measure fatigue and cannot be made direct comparison with the RR data 
from our study. 
PSF is a multifactorial phenomena that involves both physiological and 
psychosocial properties.20  One particular model described by Piper and colleagues in 
1987 addressed the multidimensional nature of fatigue and suggested that the 
contributing factors of fatigue can be perceptual, physiological, biomechanical, and 
behavioral.32  According to Portenoy’s integrated fatigue model52  developed based 
on cancer patients, EF is closely associated with factors that are physiologic (e.g. 
inactivity and  physical deconditioning) than those that are psychosocial (e.g. 
depression and anxiety).  On the other hand, chronic pain, medical treatment side 
effects, sleep disorders, and depression may better describe chronic fatigue.  These 
variations may explain the contradicting findings between current and previous 
investigations in regards of the relationship between depression and fatigue.  It is our 
postulation that the impact of depression may be more influential in fatigue that is 
chronic is nature than in EF.  In addition, we observed the existence of baseline 
fatigue in majority of people post-stroke and the evidence of a distinct construct of 
PSF that is persistent and unique from EF (Chapter 2).  Future studies should consider 
depressive symptoms as one of the main psychological factors contributing to the 
type of PSF that is chronic in nature. 
 
3.6 Conclusion 
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We found that aerobic fitness is a strong independent predictor of exertion 
fatigue (EF) in people post-stroke with fatigue complaints.  PSF is prevalent and can 
have severe negative impacts in people post-stroke; it is crucial to acknowledge that 
EF is a unique construct of PSF that differs from other types of fatigue that are 
persistent or chronic in nature.  In addition, our data suggests a direct relationship 
between aerobic fitness level and recovery rate and an inverse relationship between 
aerobic fitness level and EF.  It is important for clinicians to understand the nature of 
fatigue and identify potential contributing factors, and to implement individualized 
therapeutic treatment. 
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Figure 3.1 Scatterplot illustrating the relationship between RR and EF. 
RR – Recovery Rate 
EF – Exertion Fatigue 
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Figure 3.2 Scatterplot illustrating the relationship between RR and VO2peak. 
RR – Recovery Rate 
VO2peak – Peak Oxygen Uptake 
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Table 3.1 Participant characteristics (n = 21). Values are means + SD. 
Characteristics     Values 
Men / women      12 / 9     
Stroke lesion side: right / left / brain stem  15 / 4 / 2 
Stroke subtype: ischemic / hemorrhagic  18 / 3  
Age (years)      59.5 ± 10.3 
Time post-stroke (years)    4.1 ± 3.5 
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Table 3.2 Outcome measures (n = 21). Values are means + SD. 
Outcome Measures       Values 
EF      62.4 ± 29.3 
VO2peak (ml/kg/min)    16.2 ± 6.5 
FMTM     70.8 ± 28.8 
GDS      10.2 ± 7.3 
RR (%)     37.0 ± 17.3 
 
EF – Exertion Fatigue 
VO2peak – Peak Oxygen Uptake 
FMTM – Fugl-Meyer Total Motor 
GDS – Geriatric Depression Scale  
RR – Recovery Rate 
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Table 3.3 Pearson correlation among variables. 
 
 
Variable EF VO2peak 
FMTM 
Score GDS Score RR 
  EF 1.000  
  VO2peak 
(ml/kg/min) **-.582 1.000  
  FMTM Score -.270 .404 1.000  
  GDS Score .221 -.057 .159 1.000 
  RR **-.649 **.891 .495 -.123 1.000
**. Correlation is significant at the 0.01 level (2-tailed). 
 
EF – Exertion Fatigue 
VO2peak – Peak Oxygen Uptake 
FMTM – Fugl-Meyer Total Motor 
GDS – Geriatric Depression Scale  
RR – Recovery Rate 
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Table 3.4 Linear regression model for EF. 
Linear Regression Model       
Adjusted R2       0.305 
F        9.76 
P        0.006 
Explanatory Variables   B  P____ 
VO2peak     -2.63  0.006 
FMTM     -0.41  0.845 
GDS       0.19  0.326 
 
EF – Exertion Fatigue 
VO2peak – Peak Oxygen Uptake 
FMTM – Fugl-Meyer Total Motor 
GDS – Geriatric Depression Scale  
P – Probability Values 
B – Weights 
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Chapter 4 Preface 
Chapter 2 examined the reliability and validity of the Visual Analog Fatigue 
Scale (VAFS) and found that the VAFS is a valid and reliable tool to assess fatigue in 
people post-stroke; while Chapter 3 examined the Exertion Fatigue (EF) regression 
model and found that aerobic fitness was a good predictor for EF.  In addition, we 
also found that the VAFS was sensitive to the type fatigue that is persistent and 
chronic in nature (i.e. chronic fatigue or CF).  This discovery led to the postulation 
that EF and CF may be 2 unique constructs each with its own contributing factors 
within the confine of post-stroke fatigue (PSF). 
In Chapter 4, we examined Chronic Fatigue (CF) regression model using the 
VAFS and the Fatigue Severity Scale (FSS) scores as two response variables for CF, 
and aerobic fitness, physical impairment and depression as explanatory variables 
(measured by VO2peak, Fugl-Meyer total motor, and Geriatric Depression Scale, 
respectively).  We found that depression is the independent predictor for CF 
regardless of assessment methods (VAFS or FSS). 
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4.1 Abstract 
Background and purpose: Post-Stroke Fatigue (PSF) manifestation can become a 
chronic issue that affects performance of daily activities long after stroke and leads to 
poor quality of life.  However, not many health professionals recognize the unique 
nature of chronic fatigue (CF) as part of the PSF constructs and its impact on stroke 
rehabilitation effort.  The purpose of this study was to identify the potential 
contributing factors of CF in people post-stroke.  Methods: Twenty-one people post-
stroke (12 males, 9 female, age = 59.5 ± 10.3 years; time post-stroke = 4.1 ± 3.5 
years) participated in the study.  The response variables included two CF assessments 
measured by the Visual Analog Fatigue Scale (VAFS) at rest and the Fatigue Severity 
Scale (FSS).  The explanatory variables included aerobic fitness, motor control, and 
depressive symptoms measured by VO2peak, Fugl-Meyer total motor (FMTM) scores, 
and Geriatric Depression Scale (GDS), respectively.  Results: Using stepwise 
multiple regression, we found that that depression was an independent predictor of 
CF (p < .001) and explained 95.8% of variance in CF (adjusted R2 = .958) when using 
the VAFS as the CF measure.  When using the FSS scores as the CF measure, 
depression also explained 37.8% of variance in CF (adjusted R2 = .378) as an 
independent predictor of CF (p = .002).  Conclusion: Our results indicate that 
depression or depressive symptoms may be used to predict CF in people post-stroke. 
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4.2 Introduction 
Post-Stroke Fatigue (PSF) is a prevalent issue experienced by as many as 76% 
of people post-stroke.123  PSF manifestation can become a chronic issue124  that 
affects performance of daily activities18  and leads to poor quality of life.66  However, 
not many studies recognized the unique nature of chronic fatigue (CF) as part of the 
PSF constructs and its impact on stroke rehabilitation effort. 
The North American Nursing Diagnosis Association (NANDA) has defined 
fatigue as “an overwhelming, sustained sense of exhaustion and decreased capacity 
for physical and mental work.”42  In addition, fatigue has also been defined as a 
feeling of early exhaustion, weariness, lack of energy and aversion to effort.17  
However, none of these definitions clearly differentiates different types of fatigue 
which consisted of different dimensions. 
A general classification of the fatigue dimensions includes perception, 
physiological, biochemical, and behavioral.32  In 1993, Piper described a dichotomy 
fatigue theory, which classifies fatigue as either acute or chronic.  It was proposed 
that the key differentiating factors between acute and chronic are duration, onset of 
fatigue, and the recovery rate.53  Fatigue can be associated with exertion such as 
exercise, household activities, or social activities.55  Researchers have distinguished 
the type of fatigue as “exertion fatigue” (EF). EF is acute in nature with a rapid onset, 
short duration, and short recovery period, and is commonly experienced after exertion 
of physical power or use of mental effort.53, 55, 56  On the other hand, “chronic fatigue” 
(CF) is defined as a state of weariness unrelated to previous levels of exertion, and is 
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associated with pathological factors.53, 56  The difference between EF and CF is that 
CF does not necessarily have a relationship with the performing of activities, while 
EF is directly related to activities.36  Due to the close association between CF and 
underlying medical conditions,28  the impact and ramification of CF cannot be 
neglected.  
What exactly is CF?  The previous consensus is that fatigue that persists 6 
months or longer can be considered as CF.28, 133  The cause of CF is uncertain; several 
factors have been considered to contribute to CF such as depressive symptoms,14, 58-60  
cancer related treatments,35, 57, 134  and medication side-effects.35  In people post-
stroke, researchers have proposed several potential contributing factors specific to 
PSF.20  Multiple factors could contribute to PSF such as deconditioning, physical 
impairment, disuse, sleep disorders, medication side effects, and depression.  
However, it was unclear which factors contribute to different types of PSF.  In the 
present study, three variables were considered key contributors to CF to examine the 
PSF issue in people post-stroke – depression,11, 14-16, 20  aerobic fitness,18, 20, 65  and 
physical impairment.14, 15, 20, 65 
To date, depression is considered the most influential factor associating with 
CF in primary care40  and is the only identified factor with a significant relation to 
PSF.14, 17, 59  In people post-stroke, researchers have suggested that depression and 
depressive symptoms should be considered or controlled66  while acknowledging 
other factors may also play a role in contributing PSF.64  Interestingly, fatigue has 
been found to exist independently of depression in survivors of stroke.11, 14-16  In 
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2005, Choi-Kwan and colleagues conducted a mail-survey study in 220 people post-
stroke to evaluate the characteristics of and the factors associated with PSF.16  They 
reported that 57% of people post-stroke reported fatigue problems, while 24% of 
which also reported depression complaint.  The authors concluded that fatigue is a 
prevalent issue among survivors of stroke; and fatigue can exist independently of 
depression.  In the present study, depression was assessed as a potential predictor of 
CF using the Geriatric Depression Scale (GDS).74  
Previous research has revealed that aerobic fitness is reduced by 
approximately 50%  in people post-stroke;10, 45, 77, 79  a comparable reduction was 
reported in ambulatory capability by conducting a six-minute-walk test.78, 80  In 2006, 
Michael and colleagues investigated how aerobic fitness, mobility deficit, ambulatory 
activity, self-efficacy for falls, and social support are related to chronic fatigue in 53 
people post-stroke.65  Their finding did not show a direct association between aerobic 
fitness and fatigue, which conflicts with what previous researchers have suggested.18, 
20  In addition, a recent exercise intervention study in people with CFS suggests that a 
six-month aerobic training improved both physical and psychosocial dimensions of 
chronic fatigue.135  Therefore, further investigation is needed to determine the true 
role of aerobic fitness in CF in people post-stroke.  In this study, VO2peak was 
assessed as a potential predictor of CF using a maximal effort graded exercise test on 
a total body recumbent stepper.83 
Although it has previously been suggested that CF may not be related to 
muscle fatigability;133  researchers who examined fatigue in people post-stroke have 
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considered physical impairment as a potential contributing factor to PSF.14, 16, 20, 65, 66  
Survivors of stroke often experience the increased energy expenditure due to 
limitations such as limited range of motion, muscle tone, mal-alignment, and other 
musculoskeletal problems, which lead to poor biomechanical efficiency (e.g. 
inadequate gait due to the inability to activate normal motor patterns).78  In a 2006 
study that examined pain and fatigue, patient characteristics, stroke type, stroke 
severity, stroke risk factors, and fatigue were assessed in 253 people post-stroke at 
baseline and 1 year post-stroke.71  Fatigue was assessed by asking the subjects 
whether they had experienced fatigue which had started after the stroke.  After 1 year, 
survivors were examined with respect to residual impairment, disability, cognition 
and depression.  This study reported that fatigue was associated with physical 
disability and sleep disturbances.  In this study the level of motor control was 
reflected by the FM total motor score (FMTM), which consisted of the combined 
scores from the upper extremity (UE) and the lower extremity (LE) portions of the 
FM test.93 
To date, the potential contributing factors of CF following stroke remain 
undetermined.  To the author’s best knowledge, no study has yet identified predictors 
of CF in people post-stroke using quantifiable outcome measures as predictors.  The 
present study aimed to identify the potential contributing factors of CF in people post-
stroke using multiple linear regression where the response variable are CF measures 
(measured by FSS and VAFSat_rest); and the explanatory variables are depressive 
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symptoms (measured by GDS), aerobic fitness (measured by VO2peak), and motor 
control (measured by FMTM). 
 
4.3 Methods 
Experimental Design 
This study used a convenience sample and a cross-sectional design to 
determine the predictors of CF in people post-stroke using depressive symptoms, 
aerobic fitness, and motor control as potential contributing factors. 
 
Participants 
Twelve men and 9 women (59.5 ± 10.3 years, 4.1 ± 3.5 years post-stroke) 
participated in the study.  Individuals were recruited from local stroke support groups 
and the ASTRA (Advancing Stroke Treatment through Research Alliances) 
participant database. To be included in this study, all participants must: 1) have a 
diagnosis of stroke > 6 months and < 5 years ago, 2) have the ability to perform the 
exercise movement on a total body recumbent stepper, 3) receive medical clearance 
from their primary care physician to confirm that subject is medically stable and able 
to participate in exercise, and 4) score < 2 on a dementia screening tool, the AD8.114, 
115  Subjects were excluded from the study if they presented with any of the 
following: 
• Hospitalization for myocardial infarction, heart surgery, or congestive heart 
failure during the preceding 3 months. 
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• Recent symptoms of chest discomfort. 
• Resting blood pressure of 160/100 or greater. 
• Currently using a pacemaker. 
• Currently smoking or significant pulmonary pathology. 
• Alcoholism or alcohol dependency. 
• Recreational drug use. 
• Medication change within the duration of the study (e.g. antidepressants, 
cardiac medications). 
 
The Human Subjects Committee at the University of Kansas Medical Center 
approved the study.  Institutionally approved informed consent was obtained in 
writing prior to participation in the study. 
 
Procedure 
The experiment consisted of 2 visits. One visit involved assessment of chronic 
fatigue, level of motor control, and depressive symptoms. The other visit involved an 
assessment of the peak oxygen uptake using a calibrated total body recumbent stepper 
(NuStep, Inc; 5111 Venture Drive Suite 1, Ann Arbor, MI 48108).  The 2 visits were 
scheduled 24-48 hours apart to allow recovery. 
 
Variables 
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Fatigue Assessment.  Chronic Fatigue (CF) was measured by the Fatigue 
Severity Scale (FSS) and the Visual Analog Fatigue Scale (VAFS).  The FSS is a 9-
item scale that has been shown to be reliable and valid to assess fatigue level over the 
previous week.34  The VAFS consists of possible score ranges from 0 to 100, 
measured in millimeters on a 10cm vertical line using a pen.  It was administered to 
assess subject’s level of fatigue at rest (VAFSat_rest).  The score was obtained by 
measuring the line from “No Fatigue” to the point indicated by the subject that 
represents their fatigue level.  The VAFS has been reported to be a good reliability, 
responsiveness, and validity to assess fatigue in people post-stroke (Chapter 2). 
 
Geriatric Depression Scale (GDS).   The GDS is a questionnaire that includes 
30 items that refer to affective, cognitive, and behavioral symptoms of depression to 
assess mood.  It has been tested and used extensively with the older population with 
good validity and reliability.74, 125  The possible score ranges from 0 to 30. 
 
Aerobic Fitness (VO2peak).  To assess aerobic fitness, a maximal effort graded 
exercise test was conducted using a calibrated metabolic cart and the mTBRS-XT 
protocol our lab has developed specifically for people post-stroke.83  Subjects were 
asked to refrain from eating food for an hour and drinking caffeine for 2 hours prior 
to the test.  According to the test protocol, subjects stepped at 80 steps-per-minute 
(SPM) with a gradually increasing level of resistance.  A cool-down period of 4 
minutes followed the end of the test.  Each subject’s ECG was monitored by a 12-lead 
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ECG system during the exercise test.  The exercise test was terminated using the 
following criteria: (1) the participant reached volitional fatigue and requested to end 
the test, (2) the participant’s VO2peak plateaued or decreased despite continuation of 
exercise, (3) the participant was unable to maintain the cadence, or (4) an adverse 
cardiovascular event or response to the exercise test was observed.  The successful 
completion of the maximal effort graded exercise test (measured in VO2max) was 
determined by reaching 1) the predicted maximal heart rate [(220-age), and 2) the 
respiratory exchange ratio (RER > 1.1), and 3) plateau of VO2 values despite 
continuation of exercise.118  When the subjects were unable to achieve their maximal 
effort, the aerobic fitness level at the peak values were collected (measured in 
VO2peak).  
 
Fugl-Meyer (FM).  The FM was used to determine the level of motor function 
in the hemiparetic limbs following stroke.  The FM is a reliable and valid tool that 
was specifically designed as a clinical measure of sensorimotor impairment for 
stroke.93  The total possible score is 124, which consists of sensation (FMSEN - 24), 
upper extremity (FMUE - 66), and lower extremity (FMLE - 34).  Because the 
fatigue-inducing exercise in this study required motor performance of all four limbs, 
the combined total motor (FMTM) scores of the FMUE and FMLE were determined 
(FMTM = FMUE + FMLE)95  and used for analyses. 
 
Data Analysis 
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SPSS 16.0 (SPSS, Inc; 233 S. Wacker Drive 11th Floor Chicago, IL 60606) 
statistical software was used to perform all statistical analysis.  Descriptive statistics 
were calculated; correlations among variables were calculated with the Pearson 
correlation coefficient.  Histograms for each variable were analyzed for normal 
distributions, and scatterplots were analyzed for outlying scores.  Stepwise multiple 
regression models with 3 predictors (GDS score, VO2peak, and FMTM score) were 
calculated for chronic fatigue (CF), where the response variables were FSS and 
VAFSat_rest scores.  The validity of each model was assessed through analysis of 
colinearity statistics (variance inflation factor) and Q-Q plots of unstandardized 
residuals. 
Independent t-test was performed to determine differences in fatigue and GDS 
measures between male and female.  In addition, five secondary factors – sex, stroke 
lesion side (i.e. left, right), stroke subtype (i.e. ischemic, hemorrhagic), sleep apnea 
(i.e. sleep apnea, no sleep apnea), sleep medication (i.e. medication, no medication), 
depression medication (i.e. anti-depressant, no anti-depressant) were documented to 
obtain descriptive data.  In addition, we also explored the relationship between CF 
and other variables from this body of work using the Pearson correlation coefficient, 
more specifically, exertion fatigue (EF), recovery rate (RR), and VAFSat-rest (Chapter 
3).  A 0.05 level of significance was used for all statistical tests. 
 
Sample Size 
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 Initially, it was proposed that 30 subjects with chronic stroke will be 
recruited.  In order to maximize limited resources and to avoid over-recruitment of 
subjects, a planned interim analysis was conducted after the completion of data 
collection for 20 subjects. The goal of this analysis was to determine whether further 
recruitment is required in order to satisfy statistical significance.  To reduce the 
chance of making a type I error, alpha level was set at 0.01 for the interim analysis. 
Power calculations indicated that for the interim analysis, the twenty subjects 
had 70% power to detect explanatory variables in a multiple linear regression (with 
three explanatory variables) with an R-square of 0.27 or greater and have 80% power 
to detect explanatory variables with an R-square of 0.31 or greater.  These 
calculations used were done at the alpha = 0.01 level, as we conducted an interim 
analysis after twenty subjects (nQuery Advisor 6.01, 1995-2005). 
 
4.4 Results 
Data was collected from twenty-one individuals with chronic stroke.  Subject 
characteristics and descriptive data of secondary factors are shown in Table 4.1; 
descriptive statistics of all variables are shown in Table 4.2.  Using Pearson’s 
correlation coefficient, significant correlations were found for FSS and GDS (r = 
0.639; p = 0.002), and for VAFSat_rest and GDS (r = 0.980; p < 0.001), as shown in 
Figure 4.1 and 4.2.  The complete results of correlation among variables are shown in 
Table 4.3. 
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Using stepwise multiple regression, we found the regression models for the 
CF with 2 response variables (FSS and VAFSat_rest) and 3 explanatory variables (GDS 
score, VO2peak, and FMTM score) were statistically significant.  GDS score was found 
to be a significant individual factor that explained 37.8% of variance in CF when 
using the FFS as the fatigue measure; and 95.8% of variance in CF when using the 
VAFSat_rest as the fatigue measure.  The results of these models are presented in Table 
4.4. 
Using independent t-test, significant differences were found between male and 
female in terms of FSS, VAFSat_rest, and GDS scores as indicated in Table 4.5.  
Lastly, we did not find any relationship for CF and EF (r = 0.329; p = 0.145) or for 
CF and RR (r = -0.132; p = 0.567), but a significant positive correlation for CF and 
VAFSat-rest (r = -0.752; p < 0.001), 
 
4.5 Discussion 
Although both of our regression models suggest that depression is an 
independent predictor of CF, the variance explained in each model differs due to 
different response variables used to represent CF; and the results should be 
interpreted with caution.  In the model where CF was represented by the VAFS, 
fatigue was measured in real time (i.e. at rest).  Although it was unrelated to exertion 
level and it appeared to be persistent on separate days, its nature may be different 
from the type of fatigue measured by the FSS.  The type of fatigue measured by the 
VAFS at rest could be viewed as “baseline fatigue” and may be more related to 24-
 108
hour sleep and wake cycles also known as the circadian cycle.  As previously 
discussed (Chapter 2), we found evidence of baseline fatigue in most subjects (20 out 
of 21) at rest prior to fatigue-inducing exercise using the VAFS.  This discovery 
indicates that this type of baseline fatigue can exist independently of physical stress, 
which is persistent and chronic in nature and may explain the strong relationship with 
the CF score measured by the FSS.  One possible explanation may the testing time of 
the day in this study.  In order to capture fatigue, we asked subject to participate the 
testing sessions in the afternoon.  It is possible that the VAFSat_rest captured a type of 
fatigue that is sensitive to activity and rest cycle during the day (possibly circadian 
fatigue).  However, this study was not designed to identify or differentiate circadian 
fatigue.  Future study is needed in order to investigate the nature of baseline fatigue 
detected by the VAFS and its association with circadian cycle (e.g. change in fatigue 
level through time). 
On the other hand, although less variance was explained using FSS as the 
response variable in the regression model, FSS was designed to capture fatigue level 
experienced over a 2-week period, which was chronic in nature and perhaps more 
appropriately describing CF in people post-stroke.  An FSS score > 4 has been 
considered fatigued in people with multiple sclerosis.34  In our study, the average FSS 
score was 4.2 ± 1.7, similar to scores documented in previous fatigue studies in 
people post-stroke (4.1 ± 1.3 ~ 4.7 ± 1.3).64, 66  These results suggest the possibility 
that people post-stroke may be more likely to experience chronic fatigue.  
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Our results confirm with previous studies11, 14  and suggest that depression is a 
significant factor relating to fatigue in people post-stroke.  Post-stroke depression 
(PSD) is defined as depression occurring after a cerebrovascular accident and is the 
most frequent psychiatric complication of stroke.136  Many symptoms that are 
commonly experienced after stroke such as cognitive impairment, aphasia, functional 
impairment, and social isolation are also viewed as risk factors to PSD;137  which may 
explain the close association between stroke and depression.  Although the 
pathophysiology of PSD is still debated, researchers have proposed various 
hypotheses.  Some proposed a biological hypothesis that suggests the impact of stroke 
on neural circuits involved in mood regulations and found correlations between PSD 
and right hemisphere stroke;138  while others suggested that social and psychosocial 
stressors associated with stroke are primary causes of PSD.137  Although there’s no 
solid evidence to support these hypotheses, the relationship between depression and 
stroke cannot be denied. 
In 1999, Ingles and colleagues conducted a survey study in a community 
setting in order to investigate the frequency and outcome of fatigue, its impact on 
functioning, and its relationship with depression in people post-stroke.11  They 
administered the self-reported Fatigue Impact Scale (FIS) that measures the presence 
and severity of fatigue and its impact on cognitive, physical, and psychosocial 
functions to 181 people post-stroke.  In addition, they also administered the Geriatric 
Depression Scale (GDS) to measure the severity of depressive symptoms as did in our 
study.  Out of the 88 participants who met the criteria and participated, they found 
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that 68% of participants reported fatigue problems, while 40% of which were 
depressed. 
In 2001, Van der Werf and colleagues conducted a survey study to assess the 
relationship between PSF and depression and levels of physical impairment.14  
Fatigue was measured using the Checklist Individual Strength (CIS); while 
depression was measured by the Beck Depression Inventory for Primary Care (BDI-
PC).  The CIS is a 20-item self-report questionnaire that captures four dimensions of 
fatigue (i.e. subjective experience, reduction in motivation, reduction in activity, and 
reduction in concentration).75  They found that 20% of people post-stroke reported 
elevated depression scores; and that depression explained 11% of the variance in 
fatigue; while our regression models indicated that depression explained 37.8% of 
variance in CF.  Both the FSS and the CIS are questionnaire-based measures that 
evaluate fatigue over a 2-week period.  However, the dimensions of the CIS 
characterize depression as well as fatigue symptoms, which may be confounding.  It 
is unknown if the CIS can differentiate depression from fatigue.  In addition, BDI-PC 
used to measure depression in the previous study is a short screening scale that 
consists of seven items and produces only a binary outcome of "not depressed" or 
"depressed" for patients above a cutoff score of 4.139  Compare to the BDI-PC, the 
GDS consists of 30 items and meaures the severity of depressive symptoms with a 
continous score, not outcome dignosis with a cutoff score.  These differences could 
also contribute to the discrepency in finding between the previosu and present study.  
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Nevetheless, the association between depression and fatigue can be agreed by 
literature in general. 
It is important to acknowledge that depression does not explain the variance in 
CF exclusively according to our models.  In our study, although the CF score 
(measured by the FSS) showed significantly moderate correlation with the GDS 
score, these two questionnaires each possess unique items which measure distinctive 
psychometric qualities of subjects (Appendix II & III, respectively).  PSF is a 
multifactorial phenomena that involves both physiological and psychosocial 
properties;65  and researchers have suggested that fatigue can exist independently of 
depression.11, 16  According to Portenoy’s integrated fatigue model,52  CF can be 
closely associated with factors that are either physiologic (e.g. chronic pain) or 
psychosocial (e.g. depression).  Chronic pain, systemic disease, medical treatment 
side effects, and sleep disorders-related sleep deprivation could contribute to chronic 
fatigue in people post-stroke.  Although we collected information regarding stroke 
lesion side, stroke subtype, sleep apnea, sleep medication, and depression medication, 
we did not have sufficient numbers of sample to perform subgroup analyses. 
It has been previous established that pain or discomfort symptoms are more 
frequently reported by women as compared to men.140  Our secondary analysis 
revealed that female survivors of stroke have a significantly higher level of CF than 
male counterparts as illustrated in Figure 4.1.  Similar finding regarding fatigue and 
gender differences was found in a different clinical population.141  In 2008, Cain and 
colleagues conducted an investigation that compared gender differences in people 
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with irritable bowel syndrome (IBS)141  and found that female participants (both pre-
menopausal and post-menopausal) reported significantly more joint and muscle pain, 
stress, and fatigue than male.  Furthermore, this effect was found stronger in post-
menopausal women than pre-menopausal women, which suggested a possible 
relationship between biologic factors (e.g., sex hormones) and gender-related 
differences in clinical populations.  In addition, we also found significantly higher 
depression scores in female survivors of stroke than male as previous studies 
suggested.142-144  Depression after stroke can be detrimental as it has been associated 
with an increased risk of suicide in female survivors of stroke.145  In a 2001 study that 
investigated the frequency of depression in people several years after stroke;144  
ninety-nine survivors of stroke were examined at baseline and 7 years later.  The 
study found that the frequency of depression in female survivors of stroke was 
significantly higher than male.  Figure 4.1 indicates a cluster of female subject who 
reported higher depression as well as fatigue.   
It has been well documented that women consistently report greater numbers 
of physical symptoms more frequently than men.146   Theories to account for this 
gender difference include physiological, sociocultural, and psychological.140, 146   
In 1994, Kroenke and colleagues conducted a study to assess gender differences for 
specific symptoms in 1000 patients from four primary case sites and assessed how 
much of these differences were attributable to psychiatric comorbidity.140  The effect 
of gender on symptom reporting was assessed by multivariate analysis, adjusting for 
depressive and anxiety disorders as well as age, race, education, and medical 
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comorbidity. They fund almost all symptoms were reported more commonly by 
women, especially physically unexplained symptoms; and gender was determined the 
most important demographic factor associated with symptom reporting, followed by 
education.  The authors concluded that most physical symptoms are typically reported 
at least 50% more often by women than by men; and gender influences symptom 
reporting in patients independent of psychiatric comorbidity.140 
Lastly, CF has also been attributed to chronic pain,52  a commonly 
experienced symptom in people post-stroke.147, 148  However, pain was not assessed in 
the present study.  Future studies should consider sex differences and explore 
additional factors (e.g. pain) that may potentially contribute to chronic fatigue in 
people post-stroke. 
 
4.6 Conclusion 
We found that depression is an independent predictor of chronic fatigue (CF) 
in people post-stroke.  In addition, our data also suggests that female survivors of 
stroke have a significantly higher level of fatigue and depression than males.  PSF is 
prevalent and can have severe negative impacts in people post-stroke; it is crucial to 
acknowledge that CF is a unique construct of PSF that differs from other types of 
fatigue that are exertion-related and acute in nature.  Before individualized 
therapeutic treatment can be implemented, clinicians must be able to identify the 
nature of fatigue and its contributing factors in people post-stroke. 
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Figure 4.1 Scatterplot illustrating the relationship between FSS and GDS scores. 
CF – Chronic Fatigue score (measured by the Fatigue Severity Scale) 
GDS – Geriatric Depression Scale 
0 – Female 
1 – Male 
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Figure 4.2 Scatterplot illustrating the relationship between VAFSat_rest and GDS 
scores. 
VAFSat_rest – Visual Analog Fatigue Scale at rest 
GDS – Geriatric Depression Scale 
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Table 4.1 Participant characteristics (n = 21). Values are means + SD. 
Characteristics     Values 
Men / women      12 / 9     
Age (years)      59.5 ± 10.3 
Time post-stroke (years)    4.1 ± 3.5 
Stroke lesion side: right / left / brain stem  15 / 4 / 2 
Stroke subtype: ischemic / hemorrhagic  18 / 3  
Sleep apnea: yes / no     9/12 
Sleep medication: yes / no    4/17  
Depression medication: yes /no   9/12 
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Table 4.2 Outcome measures (n = 21). Values are means + SD. 
Outcome Measures       Values 
Response Variables 
FSS         4.2 ± 1.7 
VAFSat_rest        7.2 ± 4.3 
 
Explanatory Variables 
GDS       10.2 ± 7.3 
VO2peak (ml/kg/min)     16.2 ± 6.5 
FMTM      70.8 ± 28.8 
 
FSS – Fatigue Severity Scale 
VAFSat_rest – Visual Analog Fatigue Scale at rest 
GDS – Geriatric Depression Scale  
VO2peak – Peak Oxygen Uptake 
FMTM – Fugl-Meyer Total Motor 
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Table 4.3 Pearson correlation among variables.  
 
 
Variable FSS VAFSat-rest GDS Score VO2peak 
FMTM 
Score 
  FSS 1.000  
  VAFSat rest **.752 1.000  
  GDS Score  **.639 **.980 1.000  
  VO2peak 
(ml/kg/min) -.125 -.065 -.057 1.000 
  FMTM Score .142 .149 .159 .404 1.000
**. Correlation is significant at the 0.01 level (2-tailed). 
 
FSS – Fatigue Severity Scale 
VAFSat_rest – Visual Analog Fatigue Scale at rest 
VO2peak – Peak Oxygen Uptake 
FMTM – Fugl-Meyer Total Motor 
GDS – Geriatric Depression Scale  
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Table 4.4 Linear regression model for CF measures. 
Regression Model with FSS as Response Variable   
Adjusted R2       0.378 
F                 13.130 
P        0.002 
Explanatory Variables   B  P____ 
GDS       0.149  0.002 
VO2peak     -0.089  0.628 
FMTM      0.041  0.824 
 
Regression Model with VAFSat_rest  as Response Variable  
Adjusted R2       0.958 
F               459.717 
P               < 0.001 
Explanatory Variables   B  P____ 
GDS       0.574          < 0.001 
VO2peak     -0.009  0.848 
FMTM     -0.007  0.882 
 
FSS – Fatigue Severity Scale 
VAFSat_rest – Visual Analog Fatigue Scale at rest 
GDS – Geriatric Depression Scale  
VO2peak – Peak Oxygen Uptake 
FMTM – Fugl-Meyer Total Motor 
P – Probability Values 
B – Weights 
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Table 4.5 Sex differences in fatigue and depression measures. 
 
 
Variable 
 
Sig. (2-tailed) Sex n Mean SD 
FSS 0.050 Female 9 4.9844 .94683
Male 12 3.5417 1.88456
VAFSat_rest 0.016 Female 9 9.67 2.646
Male 12 5.33 4.355
GDS 0.017 Female 9 14.44 4.851
Male 12 7.08 7.292
 
n – Subject Number 
SD – Standard Deviation 
FSS – Fatigue Severity Scale 
VAFSat_rest – Visual Analog Fatigue Scale at rest 
GDS – Geriatric Depression Scale 
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Chapter 5 
 
 
 
 
 
 
 
 
 
Discussion and Conclusions 
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5.1 Summary of Findings 
The work presented here was undertaken to help characterize the nature of 
post-stroke fatigue (PSF).  Specifically, this research fills the void in the literature by 
establishing a reliable fatigue assessment and distinguishing two distinct types of 
fatigue each with its key contributing factor in people post-stroke.  The findings 
presented suggest that different factors could contribute to different types of fatigue; 
differentiated findings such as these are important both to validate theoretical models 
of post-stroke fatigue and to guide rehabilitation practice.  Through this work and the 
follow-up studies beyond, it is hoped that a better understanding will be gained of the 
challenges faced by those who experience post-stroke fatigue.  
 
Chapter 2. Reliability, Responsiveness, and Validity of the Visual Analog Fatigue 
Scale to Measure Exertion Fatigue in People with Chronic Stroke 
 Assessing PSF is difficult due to its subjective nature and the ambiguity of 
what’s being measured.  In addition, although many questionnaires and scales are 
available in the literature, none attempts to distinguish exertion fatigue (EF) from 
chronic fatigue (CF) using physiologic measures, nor was any specifically designed 
for survivors of stroke.  In an attempt to resolve this issue, we developed the Visual 
Analog Fatigue Scale (VAFS) and conducted experiments to test its effectiveness. 
The focus of Chapter 2 was to determine the reliability, responsiveness, and 
validity of the VAFS to assess PSF in people with chronic stroke.  We designed a 2-
visit experiment with 14 days between visits.  The first visit involved a fatigue-
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inducing exercise and VAFS at 3 different time points (i.e. at rest, post-exercise, post-
recovery).  Physiologic measures were recorded during exercise (i.e. heart rate and 
blood pressure).  A second visit was scheduled 14 days after the first visit with 
identical testing procedures.  The results suggested good intra-rater reliability for the 
VAFS measures taken during the 2 separate sessions and a strong relationship for 
between the VAFS and physiologic measures.  It was determined that the VAFS was 
a reliable and valid tool to measure fatigue level at all time points and was sensitive to 
fatigue change due to exercise. Therefore, the VAFS was utilized to measure both EF 
and CF. 
 
Chapter 3. Predictors of Exertion Fatigue in People Post-Stroke 
To identify the potential contributing factors of EF in people post-stroke, we 
used multiple linear regression analysis where the response variable was EF and the 
explanatory variables were aerobic fitness (measured by VO2peak), motor control 
(measured by FMTM), and depressive symptoms (measured by GDS).  Data was 
obtained from the first visit.  Using stepwise linear regression, the results revealed 
that the regression model for the EF with 3 variables (VO2peak, FMTM, and GDS 
scores) was statistically significant, while VO2peak was a significant individual factor 
that explained 30.5% of variance in EF.  Therefore, these results suggested that 
aerobic fitness is a key contributing factor to EF in people post-stroke. 
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Chapter 4. Predictors of Chronic Fatigue in People Post-Stroke 
The focus of Chapter 4 was to identify the potential contributing factors of CF 
in people post-stroke.  We used a parallel model similar to analysis used in Chapter 3 
to carry out multiple linear regression analysis where the response variable was CF 
and the explanatory variables were aerobic fitness (measured by VO2peak), motor 
control (measured by FMTM), and depressive symptoms (measured by GDS).  Data 
was obtained from the first visit.  Using stepwise linear regression, we found that the 
regression model for the CF with 3 variables (VO2peak, FMTM, and GDS scores) was 
statistically significant, while GDS was a significant individual factor that explained 
up to 37.8% of variance in CF.  Therefore, these results suggestd that depression is a 
major contributing factor to CF in people with chronic stroke. 
 
5.2 Possible Mechanisms for Post-Stroke Fatigue 
Exertion Fatigue 
In the present body of work, it was found that aerobic fitness is the key 
contributing factor to EF (Chapter 3).  It has been suggested that any factor that 
interferes with the ability to maintain adequate oxygen levels in the blood can lead to 
fatigue.32  More specifically, the decrease of hematocrit values and hemoglobin 
counts may contribute to O2 deficit and lead to fatigue.  A recent study has identified 
hemoglobin as one of the biomarkers to explain possible fatigue mechanisms in 
women with breast cancer who received chemotherapy.149  The authors further 
suggested that measurement of serum bilirubin can be considered as a potential 
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marker by evaluating hepatobiliary and enthropoietic function of red blood cells for 
future fatigue studies. 
In addition, accumulation of several metabolites has been associated with 
fatigue.51  In people post-stroke, the decrease of aerobic fitness and the accumulation 
of lactate acid is a likely mechanism for PSF.  It is well-known that repetitive muscle 
activities can produce an accumulation of lactic acid, which can cause the muscle 
fiber contraction force to decrease.150  During anaerobic activities (e.g. lifting of 
heavy household objects) or the anaerobic phase of exercise (e.g. first few minutes of 
jogging), when the rate of demand for energy is high, lactate is produced faster than 
the ability of the tissues to remove it and concentration level begins to rise.  This is 
less a concern in the healthy population because the increased lactate can be removed 
via a metabolic pathway known as the Krebs cycle, which refers to the oxidation of 
lactate to pyruvate by oxygenated muscle fibers (Type-I fibers) then used as fuel.150  
However, in people post-stroke, the efficiency of this metabolic pathway may be 
hampered by the reduction of aerobic fitness capacity (or lack of Type-I fibers), 
which can exacerbate the accumulation of lactic acid beyond normal level and lead to 
delayed recovery.  In this body of work, we found a positive relationship between 
aerobic fitness and recovery rate (RR); and a negative relationship between EF and 
RR.  In other words, the better the aerobic fitness, the better the recovery after 
exercise; and the better the recovery, the lesser the fatigue experienced after exercise.  
The literature has shown that people post-stroke can benefit from aerobic exercise 
training in order to achieve a healthier lifestyle.10, 77, 78, 84  However, more work is 
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needed in order to determine the exact role of aerobic fitness in PSF mechanisms.  
Future study may consider examining the effect of exercise intervention on 
hematocrit values, hemoglobin counts, serum bilirubin, and lactic acid accumulation. 
 
Chronic Fatigue 
In agreement with previous studies that suggest a relationship between 
depression and fatigue in people post-stroke,11, 14, 16  we found that depression was a 
significantly predictor of CF in the present body of work (Chapter 4).  Although the 
underlying pathophysiology of depression is still debated, MacHale and colleagues 
have suggested the impact of stroke on mood regulation may be the cause of PSD in 
people post-stroke.138  In addition, Payne et al proposed a biochemical pathway in a 
recent cancer care study that may help explain the association between depression and 
fatigue.51 
Depressive symptoms and fatigue are believed to be connected via a 
neuroendocrine transmitter pathway.149, 151  The neuroendocrine system, specifically 
the hypothalamic-pituitary-adrenal (HPA) axis, may influence level of fatigue and 
depressive mood.51  The HPA axis is a complex set of interactions among the 
hypothalamus, the pituitary gland, and the adrenal gland, which constitute a major 
part of the neuroendocrine system that controls reactions to stress and regulates body 
processes such as mood, emotions, sexuality, digestion, immune system, and energy 
storage and expenditure.  The underlying mecahnism of fatigue and depression may 
attrribute to the dysregulation of HPA,152  which can influence the production levels 
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of serotonin and melatonin.149, 151  In addition, sex difference could also contribute to 
CF as women are more likely to experience depression and fatigue.140  Biologic 
factors such as sex hormones141  may play a role in hormonal and mood regulation. 
It is important to acknowledge that serotonin and melatonin are important 
regulators of the 24-hour sleep and wake cycles also known as the circadian cycle.153  
Melatonin production is sensitive to light intensity; more specifically, melatonin 
secretion is inhibited by light and promoted by darkness.153  Therefore, an 
individual’s natural wake and sleep cycle corresponds with melatonin production.  A 
previous study has identified melatonin as a possible biomarker to explain fatigue 
mechanisms in women with breast cancer.149  Payne and colleagues observed 
increased daytime melatonin levels over three months during chemotherapy, which 
suggested elevated fatigue intensity experienced by subjects.  Therefore, it is 
important to consider the link among depression, fatigue, serotonin and melatonin 
because serotonin may be an indicator of depression and is a precursor to melatonin.51 
Derived from the biochemical dimension of Piper’s fatigue model,32  Payne’s 
neuroendocrine theory offered a plausible explanation to address the relationship 
between depression and fatigue from a physiologic perspective.51  Although it is 
unknown whether this neuroendocrine pathway can be applied in other clinical 
populations such stroke, it provided a valuable conceptual framework for future 
research. 
Although our findings show that EF and CF each has a different predictor, it is 
important to acknowledge EF and CF may co-exist or overlap in people post-stroke as 
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PSF is multidimensional.  Specifically, survivors of stroke who experience multiple 
symptoms (e.g. lower aerobic fitness and depression) could experience both EF and 
CF throughout daily activities.  EF and CF may also share other potential factors that 
are yet recognized; further investigation is needed in order to identify additional 
contributing factors of PSF. 
 
5.3 Limitations 
Assessing VO2 
Obtaining VO2peak in people post-stroke has been a challenging throughout 
literature due to physical limitations in people post-stroke such as muscle tone, 
limited range of motion, hemiparesis, poor postural control, and poor coordination.  
Nevertheless, all participants in this presented work were able to participate in the 
maximal effort graded exercise test using the mTBRS-XT protocol.83  In our study, 5 
out of 21 subjects were able to reach their maximal effort; while the other 16 subjects 
reached their peak effort according to our study criteria.  The 5 subjects who reached 
maximal oxygen uptake had VO2 values that ranged from 19.0 ml/kg/min to 33.1 
ml/kg/min, which were higher than the group mean of 16.2 ml/kg/min.  If we were 
able to obtain VO2max from all subjects, it is hypothesized that VO2max would 
strengthen the inverse relationship found between EF and aerobic fitness in the EF 
regression model.  However, since VO2peak is an underestimation of the actual 
maximal values, the results should be interpreted with caution as only 24% our 
subjects reached their maximal aerobic fitness capacity. 
 129
Physical Impairment 
Motor control was not found predictive to either EF or CF model in the 
present body of work (Chapter 3 & 4).  On possible explanation is that although our 
fatigue-inducing protocol involved all 4 limbs, it did not challenge subject’s motor 
control ability at the highest level as it was performed on a non-weight-bearing 
instrument (i.e. TBRS).  In a previous PSF study where the fatigue-inducing protocol 
involved a distance walk, motor control was found to be a significant predictor of 
EF.154  These conflicting findings suggest that EF may be dependent of the type of 
activity involved and is task or performance-specific. 
In people post-stroke, the hemiparetic limbs require significantly more energy 
to perform movement and result in increase of energy expenditure.77, 78  This 
reduction of biomechanical efficiency can lead to unnecessary anaerobic glycolysis 
and may exacerbate lactate accumulation.  More importantly, excessive hydrogen 
ions that are produced as lactate accumulates has also been associated with decrease 
of muscle force in healthy adults.155, 156  Hydrogen ions can interfere with muscle 
excitability and impede muscle force by decreasing the number of calcium ions that 
are bound to troponin during excitation coupling.  As the result, the number of actin-
myosin contraction activity declines, thus decrease in total force output.157 
Future studies may consider incorporating muscular strength measures (e.g. 
Biodex) when investigating the role of physical impairment in PSF mechanism.  
Although some researchers have used FM as an indicator of stroke severity or 
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impairment;95-97  muscle strength is a more direct measure of muscular properties and 
could perhaps aid explaining PSF in addition to motor control ability. 
 
Sample Size 
 One of the limitations in this dissertation project is the small sample size.  
Although we were able to achieve statistical significance in our regression models, 
we were unable to perform subgroup analyses to determine group differences.  Future 
study may consider a larger sample size to validate the EF and CF models, and to 
determine fatigue difference in people with different stroke subtypes and post-stroke 
time.   
 
Visual Analogue Fatigue Scale 
 We were unable to establish normative values of the VAFS in healthy 
populations due to the limited sample size.  We acknowledge the absence of these 
comparison values as a limitation.  Future studies may consider assessing fatigue 
using the VAFS in both young and older healthy adults. 
 
Lesion Location 
Data on type of stroke and hemisphere were obtained based on subject’s 
report.  Type of stroke was classified as ischemic versus hemorrhagic; however, 
specific lesion location was not documented nor controlled for the present study.  
Although the relationship between right-hemispheric strokes and PSF has been 
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suggested,107  more studies have shown that lesion side and stroke subtype do not 
appear to contribute fatigue in people post-stroke.11, 15-17  This matter remains at 
debate as the underlying mechanism between lesion location and fatigue has not been 
clarified.  Given the limited sample size, we were unable to compare differences 
between groups based on stroke type due to limited sample size.  Future study may 
consider control for lesion location and explore its relationship with PSF.  
 
Medication 
Individuals taking antidepressants, sleep agents, and ß-blockers were not 
excluded from participating in this study.  Although the efficacy of antidepressants 
may alleviate some severity depressive symptoms, research suggests despite the 
prescription of antidepressants, depressive symptoms can persist in people post-
stroke.104  In addition, we acknowledge the side effects of sleep agents may have (e.g. 
drowsiness) on the severity of fatigue. 
ß-blockers have been associated with increased risks of depressive symptoms, 
fatigue, dizziness, hypotension and sexual dysfunction.  However, recent review 
studies158, 159  suggest no significant increased risk of depressive symptoms and only 
small increased risks of fatigue and sexual dysfunction based on previous clinical 
trials data.  Although medication was documented in the present study, we were 
unable to compare differences between groups due to limited sample size.  Future 
studies with a larger sample size may consider control or screen for antidepressants, 
sleep agents, or ß-blockers. 
 132
Pain 
Pain was not assessed in this body of work.  Although de Groot and 
colleagued suggested that pain is one of the potential contributing factor to PSF,20  
pain is often overlooked.71  Literature has shown a strong relationship between pain 
and fatigue in people undergoing cancer treatment.160  In a study of 69 women with 
lung cancer, 41% of subjects who had fatigue complains were found to experience 
frequent pain.  In addition, the severity of fatigue and pain were significantly 
correlated.160 
In 2006, Appelros documented general characteristics, stroke type, stroke 
severity, and risk factors at baseline in 377 people post-stroke.71  After 1 year, 253 
subjects were evaluated in terms of residual impairment, disability, cognition, and 
depression.  The results indicate that 11% had stroke-associated pain and 53% had 
post-stroke fatigue.  Pain was associated with depression and degree of paresis at 
baseline; while fatigue was associated with physical disability.  The authors 
concluded that it is important to recognize the presence of pain and fatigue after 
stroke due to the prevalence and potential negative impact on quality of life in people 
post-stroke.  Although the authors also suggest the possible co-existence between 
depression with pain or fatigue, pain was not analyzed as a potential contributing 
factor to PSF, and its relationship with fatigue was also not determined.  We 
acknowledge the influence pain may have on fatigue in people pos-stroke.  Future 
studies should consider investigating pain as a contributing factor to PSF. 
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5.4 Clinical implications 
With approximately 780,000 Americans experiencing stroke each year,4  and 
many of which require extensive care,5  it is the responsibility of health professional 
of all disciplines to help share the burden stroke’s health consequences.  The findings 
of the current research project may help clinicians treat people post-stroke. 
 
Fatigue Classification 
 Assessment of post-stroke fatigue is challenging.  The initial step of 
assessment should seek to identify the nature of fatigue (i.e. acute vs. chronic).  
Although there’s no universal definition of fatigue, we suggest using onset, duration, 
and recovery rate as 3 differentiating criteria described in Piper’s dichotomy fatigue 
model as illustrated in Figure 1.3.  If exertion fatigue (EF) is suspected to manifest, 
the Visual Analog Fatigue Scale (VAFS) should be administered before and after a 
fatigue-inducing exercise (e.g. distance walk) to calculate the severity of EF (EF = 
VAFSpost-exercise – VAFSat-rest).  If chronic fatigue (CF) is suspected, the VAFS can be 
administered at rest to detect the level of CF in real-time.  In addition, the Fatigue 
Severity Scale (FSS)34  can also be implemented to detect CF. 
 
Identification of Contributing Factors 
 The next step is to identify potential contributing factors.  Besides aerobic 
fitness and depression that were identified in this body work as contributing factors 
for EF and CF, respectively, clinicians should also consider other potential 
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contributing factors such as medication side effects, sleep disorders, and pain.  In 
addition to the EF/CF parallel fatigue model as shown in Figure 5.1, we suggest the 
PSF-specific contributing factors described by de Groot as illustrated in Table 1.1. 
 
Fatigue Management 
 Because PSF is multidimensional and multifactorial,20  fatigue management 
options could be either pharmacological or non-pharmacological, nevertheless, it 
should always remain cause-specific.  In other words, treatment effort should be made 
to counteract potential etiologies, if identifiable.  These treatment options may 
include improvement of aerobic fitness, management of depression, treatment of 
sleep disorder, and elimination of nonessential drugs.  Some of these options only 
pose minimal burdens to the individuals post-stroke and caregivers. 
For people post-stroke who experience exertion fatigue (EF), increase of 
aerobic fitness is likely to improve the fatigue level experienced after exercise or 
vigorous activity.  Researchers and health professionals have stressed the importance 
aerobic exercise and its related benefits;77, 161  it has been shown to increase 
physiologic measures of fitness after stroke.  In addition, sub-maximal aerobic 
exercise training for 6 weeks was found to decrease fatigue level in people with 
chronic fatigue syndrome (CFS),135  which may attribute to the increased levels of 
endorphins and serotonin as the result of exercise.  Other non-pharmacological may 
include social activities, meditation,162  music therapy.163  Nevertheless, these 
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alternative treatments may not be cause-specific to PSF; and the effects in people 
post-stroke are yet to be established. 
For people post-stroke who experience chronic fatigue (CF), alleviation of 
depressive symptoms appears to be a sensible practice according to the findings of 
this body of work.  Early diagnosis of post-stroke depression (PSD) and treatment 
may have a positive effect not only on depressive symptoms but also on the 
rehabilitation outcome of people post-stroke.164  Clinical trials revealed that only a 
small fraction of people with PSD were diagnosed, and fewer were treated.13  
Pharmacological intervention treatment such as fluoxetine for 12 weeks during the 
first 6 months post-stroke has been shown to significantly increase the survival 
rate.165  Jorge and colleagues assessed the efficacy of a 12-week antidepressant 
treatment (fluoxetine, nortriptyline, or placebo) in 104 people post-stroke in the acute 
recovery phase and found significant different difference in survival rate between 
treatment and placebo groups.  Of 53 subjects who were given full-dose 
antidepressants, 36 (67.9%) were alive at follow-up, compared with only 10 (35.7%) 
of 28 subjects who were treated with placebos.  The authors concluded that treatment 
with fluoxetine or nortriptyline for 12 weeks during the first 6 months post-stroke 
significantly increased the survival of both depressed and nondepressed patients.  
This finding provided a feasible pharmacological interventions for people who have 
CF as their main fatigue complaint. 
 
Depression and Fatigue 
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Although the pathophysiology of post-stroke depression is still debated, 
researchers have proposed various hypotheses from biological138  and psychosocial 
perspectives.137  It is unclear whether there’s a causal relationship between depression 
and fatigue; it is also unclear whether depression should be considered as a symptom 
of fatigue or vice versa. We acknowledge the possible role reversal of these 2 closely 
related variables.  Although there’s no solid evidence to suggest one way or another, 
the close relationship between depression and fatigue cannot be neglected.  
Regardless the possible causal relationship between depression and fatigue and its 
influence on our fatigue model, the authors concluded that treatment effort should be 
made to focus on depression intervention, whether pharmacological or not. 
 
5.5 Future Directions 
The primary purpose of the present body work was to obtain a better 
understanding of PSF by characterizing the nature of different types of fatigue in 
people with chronic stroke.  The results of this work demonstrated that aerobic fitness 
is an independent predictor of exertion fatigue in people post-stroke; while depression 
is a strong contributor of chronic fatigue. 
This project established the groundwork for PSF classification and 
contributing factor identification.  The short-term goal of this research is to continue 
characterizing the nature of PSF by expanding investigation in order to capture 
additional potential contributing factors; while the long-term goal is to develop 
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therapeutic countermeasures and evaluate its efficacy via intervention studies in 
people post-stroke. 
 
Exertion Fatigue Validation 
In order to validate our EF model and confirm EF as a valid measure of 
fatigue, future work could control for fitness level and test individual at different 
levels of exercise intensity or different times of day.  It is out stipulation that although 
subjects posses same or similar fitness level, levels of fatigue may vary. 
 
Exercise Intervention 
 To the author’s best knowledge, no studies have yet to develop a sound 
therapeutic exercise intervention program and evaluate its efficacy in people post-
stroke with fatigue complaints.  Previous research has shown that people post-stroke 
can benefit from aerobic exercise training to achieve a healthier lifestyle.10, 77, 78, 84  It 
has also been established that sub-maximal aerobic exercise training for 6 weeks 
appeared to decrease fatigue level in people with chronic fatigue syndrome (CFS).135  
The same exercise regiment may be considered in training people post-stroke. 
In addition, the effectiveness of exercise on depression has also been well 
documented.166-168  Mead and colleagues conducted a review study to determine the 
effectiveness of exercise in the treatment of depression.167   They found that exercise 
seems to improve depressive symptoms in people with a diagnosis of depression.  
However, the effect of exercise was not significantly different from that of cognitive 
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therapy.  Depression is commonly treated with antidepressants and/or psychotherapy, 
but some may prefer alternative approaches such as exercise.   
 
Exploration of Other Potential Variables 
 Pain - Although it has been suggested that pain is one of the potential 
contributing factor to PSF,20  like fatigue, pain is a commonly overlooked issue in 
people post-stroke.71  Literature has shown that pain and severity of fatigue are 
strongly correlated in people who received cancer treatment.160  However, the 
relationship between pain and fatigue and its possible role in the underlying 
mechanisms (e.g. biomarkers respond to elevated pain and stress level) in people 
post-stroke is inadequately studied.70, 71  The potential impact of pain on fatigue and 
rehabilitation cannot be neglected in people post-stroke, especially when studying 
PSF.  Future studies should consider investigating pain as a potential contributing 
factor to PSF using both quantitative (e.g. pain visual analog scale) and qualitative 
(e.g. case study) design.  Investigators could consider 1) examining the relationship 
between fatigue level, pain, and quality of life, and 2) adding pain as a variable to 
validate the fatigue models in people post-stroke.  In addition, case study with 
thorough documentation of daily pain level may be valuable in conjunction with 
quality of life assessment. 
Biomarkers - Any fluid or electrolyte imbalance can potentially influence 
neurotransmission and muscle force and result in fatigue.32  Payne and colleagues 
have identified melatonin as a possible biomarker to explain fatigue mechanisms in 
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women with breast cancer.149  Elevated daytime melatonin levels were observed 
during chemotherapy and attributed to elevated fatigue level experienced by subjects.  
In addition, cortisol has been identified as the primary marker of the HPA axis that 
may alleviate fatigue and stress.151  Although these studies were conducted in cancer 
patients, the authors suggested the implication of conceptual framework in other 
clinical population with fatigue issues.32  These biomarkers may provide valuable 
physiologic evidence and may explain the underlying mechanisms of PSF.  Future 
study may consider examining the effect of exercise intervention on biomarkers such 
as serotonin, melatonin, serum bilirubin, hemoglobin counts, and lactic acid 
accumulation. 
Circadian Fatigue - Although the contributing factors of circadian fatigue is 
still undetermined, the Visual Analog Fatigue Scale (VAFS) developed in this body 
of work can be used to detect real-time fatigue at different time points during the day, 
which provides a feasible outcome measure to investigate circadian fatigue.  In 
addition, it has established that serotonin and melatonin are important regulators of 
the 24-hour sleep and wake cycles also known as the circadian cycle.153  An 
individual’s natural wake and sleep cycle corresponds with melatonin production, 
which is sensitive to light intensity.  More specifically, melatonin secretion is 
inhibited by light and promoted by darkness.153  The dysregulation of melatonin may 
affect sleep and circadian rhythms, which can result in daytime fatigue.169  In 
addition, serotonin and is a precursor to melatonin and may be an indicator of 
depression.51  Therefore, biomarkers such as serotonin and melatonin may offer a 
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physiologic approach to study circadian fatigue.  Future study may consider 
examining the relationship between the level of circadian fatigue (measured by the 
VAFS) and the level of melatonin counts in people post-stroke. 
 
5.6 Conclusions 
The work presented in this dissertation provides a snap-shot into a grander 
picture of post-stroke fatigue.  The present findings suggest that aerobic fitness 
mainly contributes to exertion fatigue; while depression contributes chronic fatigue in 
people post-stroke.  There is little doubt that PSF consists of different constructs; each 
construct has its own contributing factors, and these contributing factors may or may 
not overlap as suggested in the parallel fatigue model shown in Figure 5.1. 
Our findings also suggest that rehabilitation professional should consider 
multiple possible contributors to a patient’s fatigue after stroke; and the treatment 
strategies should include classification of fatigue subtype, identification of potential 
contributing factor, and implementation of cause-specific therapeutic treatment, 
whether pharmacological or not.  Clinically, this is important for the rehabilitation of 
those with PSF complaints because clinicians may be able to treat people post-stroke 
with better prognosis by overcoming some of the offsetting factors.  Finally, possible 
future studies such as those outlined previously will require validation of empirical 
data.  If a thorough understanding of post-stroke fatigue can be obtained (i.e. all 
contributing factors and related mechanisms), health professions may be able to 
achieve optimal rehabilitative potential. 
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Figure 5.1. Illustration of exertion fatigue and chronic fatigue parallel models. 
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Appendix I 
 
Definitions of Fatigue Glossary 
• Acute Fatigue – Fatigue with rapid onset and quicker recovery rate.  Acute fatigue 
is considered interchangeable with exertion fatigue. 
 
• Exertion Fatigue – A state of general tiredness that is the result of over-exertion 
and can be recovered by rest.  Exertion fatigue is normative and is caused by 
extensive activities throughout daily living, with a rapid onset and shorter 
duration.  Exertion fatigue is considered interchangeable with acute fatigue. 
 
• Chronic Fatigue – A state of weariness unrelated to previous exertion levels that 
is associated with prolonged stress or pathologies.  Opposite from acute or 
exertion fatigue, chronic fatigue has a gradual onset and longer duration. 
 
• Circadian Fatigue – Fatigue that corresponds to the 24-hour sleep and wake cycles 
also known as the circadian cycle.  It is generally experienced towards the end of 
a day’s activities and can be exacerbated by sleep deprivation. 
 
• Baseline Fatigue – Fatigue that persists prior to any physical exertion that is 
possibly related to circadian or chronic fatigue.  Due to the design of this study, 
we were unable to validate the nature of this type of fatigue or to distinguish it 
from chronic or circadian fatigue. 
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